Sop: Disp 7: Standard Operating Procedure (Boots Retail Ireland LTD)

Responding to a request for an emergency supply of a
prescription-only medicine
Receive a request for an emergency supply of a prescription only medicine
YES Emergency supply not possible

Does the medicine contain a drug listed in Schedules 2, 3 or 4
unless the drug is
of the Misuse of Drugs Regulations 2017 ?
methylphenobarbitone,
NO phenobarbitone or
phenobarbitone sodium for
Who is the request for an emergency supply made by? the treatment of epilepsy
PRESCRIBER PATIENT
Is the prescriber unable to Is there an immediate need for the

NO NO
immediately furnish a Emergency supply medicine to be supplied and it is
prescription due to an not permitted impractical for the patient to obtain a
emergency? prescription without significant delay?
Responsible: Pharmacist
YES YES
Has the prescriber NO NO

Emergency supply Has the medicine previously been
undertaken to provide a
not permitted prescribed for the patient?
prescription within 72 hrs?
YES YES
NO
Confirm the details of the Is the dose reasonable and
request with the prescriber. appropriate?
If request has been received
verbally, repeat the details YES
of the request back to the
prescriber to ensure Arrange for the medicine to be supplied in accordance with
accuracy SOPs DISP 2-6.
YES • Supply only a quantity sufficient for 5 days except :
• Ointment, cream or aerosol – supply smallest
Arrange for the medicine to pack size
be supplied in accordance • Oral contraceptive – supply full cycle
with SOPs DISP 2-6 • Antibiotics for oral administration in liquid form
– supply smallest quantity which provides full
YES course
• Mark dispensing label with words “Emergency supply”
On receipt of the
• Record nature of emergency and name and address of
prescription from the
pharmacy where the medicine was previously supplied
prescriber, update the PMR
together with details of any contact with pharmacy
and daily audit report with
under “item comment”
the date of receipt.
SUPERINTENDENT PHARMACIST SIGNATURE: DATE: Review due : 01/06/2025

01/06/2023 © Boots 2023 SOP:
SUPERVISING PHARMACIST SIGNATURE: DATE: Audit due one month
DISP 7
after receipt of SOP then
annually thereafter
Version 2
Standard Operating Procedure (Boots Retail Ireland Ltd)
Standard Operating Procedure (SOP) DISP 7 V2 Training Log
Team Member Team Member* Signature and date Pharmacist** Signature and date
*Team Member: By signing this declaration you, the team member, are confirming that you have read, understood
and will comply with (i.e. follow) the SOP at all times
**Pharmacist: By signing this declaration you are confirming that the team member has received the necessary
training to follow the content of the SOP and you are satisfied that he/she is competent to undertake the tasks
identified within the SOP

Dealing with a Pharmacy Incident/Error
Any patient reporting an alleged pharmacy error must be referred without delay to the
pharmacist on duty
1. Greet the patient and introduce yourself as the pharmacist on duty. Seek to understand the alleged
pharmacy error. Request the patient to return the medicine which is alleged to have been supplied
incorrectly, ensuring to explain to the patient that this is to reduce the risk of accidental consumption
of an incorrect medicine and to assist with the investigation of the alleged error.
2. If the alleged error relates to an incorrect supply:
• Ask to see the alleged incorrect supply. Explain to the patient/ representative that doing so
can give you valuable information
• If the patient wishes to keep the medication in question, ensure that a photocopy (or a
photograph) is taken of the dispensing packaging and label(s) for your records. Re-iterate to
the patient the importance of taking steps to ensure this medicine is not accidentally taken.
• Retrieve the original prescription and check the medication dispensed against what is
stated on the prescription.
3. If a dispensing error or other pharmacy incident has occurred, apologise to the
patient/representative, even if you were not the person who made the mistake. This does not mean
you are admitting liability.
4. If the error was not identified by the patient (i.e. if it was identified by the pharmacy team, a family
member or another third party), ensure that all reasonable steps are taken to inform the patient
promptly about the error (unless in the circumstances it is neither necessary nor appropriate to do
so).
Dispensing Errors
1. If appropriate, make a supply of the correct medication ordered on the prescription.
2. If the patient has taken any of the incorrect medication, establish how long it has been taken for and
ascertain whether the patient has experienced any adverse effects.
3. Contact the prescriber to inform him/her that an error has been made and his/her patient has taken
incorrect medication. This must be done even if no harm is alleged.
4. If the patient has been harmed, provide the patient and him/her and their doctor with any relevant
information required as soon as possible.
All pharmacy incidents (including dispensing errors)
1. Inform the patient/representative what will be done about the incident. This should include:
• A thorough investigation of the root cause(s) of the error
• An action plan to minimise the risk of recurrence
2. If the patient/representative is not satisfied with the remedial actions outlined above, ascertain his/her
expectations. If you are unsure how to meet the patient’s expectations, refer the patient to the Store
Manager (in the first instance). Further support can be sought from your Area Manager or Pharmacy
Office where required.
3. All incidents must be reported to the Superintendent Pharmacist through the Pharmacy Incident & Event
Reporting System (PIERS) on BootsLive, selecting the correct form type, even if you are not the person
involved in the incident. All incidents must be recorded on PIERs within 24 hours of being reported to the
store.
Refer to PIERS for Pharmacy Teams: Quick Reference Guide available on BootsLive and
PIERS eLearning for Pharmacy Teams (ROI) for instructions on the use of PIERS

Dealing with a Pharmacy Incident/Error
All pharmacy incidents (including dispensing errors) cont.

4. Follow-up with the patient as appropriate.
Responsible:
Pharmacist
5. At the end of each month, include all dispensing incidents/errors with any near miss incidents in the
Patient Safety Review to ensure the actions are implemented to prevent recurrence.
6. Ensure all pharmacy team members are updated on the agreed Patient Safety Review actions and
understand their role in the implementation of these actions.
Investigation of Incident and Completion of PIERs Report
1. Investigate the incident and update PIERS with the findings, including the details of the actions taken
Responsible: Store Manager
to date; those planned to prevent a recurrence; who will be taking such actions and the scheduled
date for their completion. The investigation should be completed within seven days if possible.
Refer to PIERS for Pharmacy Teams: Quick Reference Guide available on BootsLive and
PIERS eLearning for Line Managers (ROI) for instructions on the use of PIERS
Any pharmacist/dispenser involved in the incident should be informed and should give their
account of the incident as part of the investigation - even if they do not work regularly in
your store (i.e. locum pharmacists)
2. Once completed, the Area Manager must review the report and investigation and move the incident
to ‘Completed’ once they are satisfied the incident has been resolved
• Any contact from a primary care organisation, other external bodies, solicitors or the
regulator must be referred to your PSM or the Superintendent Pharmacist’s Office as soon
Important
as possible.
• Referring the patient to Head Office or the offer of a letter from the Superintendent
Pharmacist’s Office should not be routine. A local resolution and open communication with
the patient can be much more appropriate and effective.
• If the patient asks for compensation, explain that his/her request will have to be referred to
the Superintendent Pharmacist’s Office for action.

01/06/2023 © Boots 2023 SOP: DISP 8
Version 3
annually thereafter


Preparation and Supply of medicines within a Boots Medisure Pack
This Standard Operating Procedure (SOP) should be followed when preparing and supplying a Medisure Pack
(Blister Pack) for a patient. It should be adhered to in combination with:
• SOP DISP 1 – Receive a prescription
• SOP DISP 2 – Label a prescription
• SOP DISP 3 – Assemble a prescription
• SOP DISP 4 – Completing a clinical check of a prescription
• SOP DISP 5 – Completing an accuracy check of a prescription
• SOP DISP 6 – Handing out a prescription
Receiving a prescription to be supplied as a Boots Medisure Pack
Responsible: Pharmacist, Dispensary Team Member
Refer to Medisure Operational Guidance on BootsLive
1. Follow the relevant steps outlined in SOP DISP 1 Receive a Prescription.

2. If the prescription is for a new patient or a patient who has not received their medicines within a Boots
Medisure Pack previously, refer the patient to the Pharmacist. The pharmacist must then:
• Assess the patient’s suitability for a Medisure Pack
Assessing a patient’s suitability for a Medisure pack is a matter of the pharmacist’s own
professional judgement. Refer to the PSI Draft Guidance for Pharmacists on the use of
Monitored Dosage Systems (MDS) available here.
• If a Medisure Pack is appropriate, the pharmacist should prepare a Medisure Patient Record Form that
outlines medicines for inclusion within the pack, medicines to be omitted from the pack (e.g. fridge
lines, effervescent medicines), and appropriate times/intervals at which medicines should be taken
(i.e. morning, noon, evening, night)
• The pharmacist should contact the patient’s prescriber should they have any queries regarding the
supply of the patient’s medicines within a Medisure Pack
3. If the patient receives their medicines within a Boots Medisure Pack regularly, the pharmacist/dispenser should
reconcile the medicines and instructions on the prescription with the patient’s Medisure Patient Record Form
to identify any changes or queries that require follow-up prior to dispensing the prescription.
Labelling a prescription to be supplied as a Boots Medisure Pack

1. Follow the relevant steps outlined in SOP DISP 2 Label a Prescription
2. Ensure that each label specifies a dosage administration time for each medicine to correlate with the times
specified on the Medisure Pack (i.e. morning, noon, evening, night).
Assembling medicines to be supplied as a Boots Medisure Pack
1. Follow the relevant steps outlined in SOP DISP 3 Assemble a Prescription.

2. Reading from the prescription, collect all the stock items required in a nestable container. If any stock is
unavailable, do not start the assembly process.
3. Once all stock is available, pass the gathered stock, prescription, labels and patient’s Medisure Patient Record
Form to the pharmacist for checking prior to assembly of the Medisure Pack.
4. Once the pharmacist has conducted the initial check, assembly of the Medisure Pack can begin. Ensure to
collect sufficient appropriate Medisure Packs (2 slots per day or 4 slots per day), wash hands, donn gloves, and
bring all supplies to the designated area of the dispensary for the preparation of Medisure Packs.
5. Using the patient’s Medisure Patient Record Form and prescription for reference, remove each medicine from
the original stock container and place the required quantity into each appropriate blister. Attach the
corresponding label to the Medisure Pack. Note the formulation (e.g. tablet or capsule), colour, shape, and
markings of each medicine on the appropriate section of the Medisure Pack. Repeat this step for each item on
the prescription that can be blistered.
Preparation and Supply of medicines within a Boots Medisure Pack
6. Check that each blister contains the correct medicines.

7. Seal the Medisure pack using the roller. If the blisters are full, the pharmacist may wish to complete a pre-
check before sealing.
8. Turn the sealed Medisure pack over. Check that the pack is completely sealed and that each blister still
contains the correct medicines. Rock gently from side to side to ensure that all tablets are secure in their
blister.
9. Include a patient information leaflet (PIL) for each item.
10. Attach a bag label to each Medisure pack and write the appropriate medication start date in the space
provided.
11. Keep all stock containers and/or empty packages that have been used in the assembly process together
with the assembled items for the pharmacist to check during the final accuracy check.
12. Assemble any items supplied outside of the Medisure Pack.
13. Pass the completed prescription to the pharmacist for check.
Completing a clinical and accuracy check of a Medisure Pack [Pharmacist]

1. Follow the relevant steps outlined in SOP DISP 4 Completing a clinical check of a prescription and SOP DISP
5 Completing an accuracy check of a prescription.
2. The accuracy check should ideally be performed by a pharmacist who has not been involved in the
assembly or labelling process. The final accuracy check can only be completed once the Medisure pack has
been sealed.
3. For all items included in the Medisure pack, check that they are appropriate to be blistered and check the
quantity of tablets included in the blisters for each time and day.
4. For each item included in the Medisure pack, check that the label specifies the dosage administration
time(s) and that these correlate with those on the Medisure pack.
5. Check the correct description of the medication is recorded on the Medisure pack for each item contained
in the pack, and that it matches the stock container and the assembled product.
6. Gently rock the Medisure pack from side to side to ensure that all medicines are securely sealed into the
blisters
7. Check the bag label against the prescription to confirm the patient’s name and address.
8. Check that the correct start date has been entered onto the Medisure pack.
9. Bring any errors to the attention of the dispenser, have them rectified immediately and record the details
on the near miss log.
10. Place the Medisure pack(s) and additional items into a bag, seal with a bag label, and store in the
appropriate area for collection. If the patient collects the medication weekly, a separate bag labelled with
the collection date should be used for each week’s supply.

01/06/2023 © Boots 2023 SOP: DISP 9
Version 2
annually thereafter


Extemporaneous Dispensing
This Standard Operating Procedure is for use in the extemporaneous dispensing of internal/external
preparations in the dispensary. It does not include CDs, aseptic products or reconstitution of dry powders
with water/ diluents. This SOP should be used in combination with the PSI Guidance for Pharmacists on
Extemporaneous Dispensing
1. Upon receipt of a prescription for an item to be prepared extemporaneously, pass to the pharmacist to assess
suitability for dispensing in store
2. Assess whether the preparation of an extemporaneous product is appropriate, taking into account:
• The availability of a suitable licensed medicine or a product which is authorised in another EEA state
and available as an exempt medicinal product in Ireland
• The availability of an extemporaneously prepared product from a specialist compounding facility
licensed by the HPRA

• The availability of a suitable alternative medicine that may be appropriate for the patient
3. Contact the prescriber to discuss the availability of suitable licensed medicine, exempt medicinal product, or
alternative medicine if appropriate. If the prescriber is agreeable to an alternative, obtain an appropriately
amended prescription
4. If the product is to be prepared extemporaneously by a specialist compounding facility or in the pharmacy,
inform the prescriber of the exempt status of such product as per SOP DISP 11 Exempt/Unlicensed Medicines
5. If preparing an extemporaneous product in the pharmacy, advise the customer the product will be prepared
extemporaneously under the supervision of the pharmacist and tell the patient when the prescription will be
ready for collection
6. Using a suitable formula for the preparation, collect all ingredients necessary to prepare the product.
7. Perform any pharmaceutical calculations, as necessary, and enter the workings into the Extemporaneous
Dispensing Record Book
8. Have the calculation checked by another competent member of staff who must be a pharmacist where the
initial calculation was performed by a non-pharmacist. Initial the Extemporaneous Dispensing Record Book to
confirm the calculation has been checked
9. Prepare the designated compounding area, ensuring that it is clean and clutter-free. Collect all equipment
needed and clean the equipment before and after use.
10. Enter details of the ingredients including batch number, expiry and manufacturer into the worksheet in the
Extemporaneous Dispensing Record Book
11. Prepare two copies of the dispensing label. Affix one label to the worksheet in the Record Book
The dispensing label must include:
• Name and quantity of preparation
• Name of patient
• Instructions for use including the route of administration, relevant cautionary and advisory labels,
and any safe handling or storage requirements
• Name, strength and quantity of all ingredients
• Batch number
• Date of preparation and expiry date
• ‘For external use only’ where appropriate
12. Weigh out/measure the relevant quantities of each ingredient. Ensure that the worksheet is completed in full
13. The pharmacist should check the accuracy of the weights and measures and initial the record book
14. Combine the products carefully and thoroughly as appropriate
15. Transfer the product into an appropriate container and attach the label and any ancillary information labels
16. Pass the product to the pharmacist for a final check and ensure that all records have been completed
17. Worksheets in the Extemporaneous Dispensing Record Book and prescriptions for extemporaneous products
must be retained for five years
01/06/2023 © Boots 2023 SOP:
DISP 10
Version 1
annually thereafter


Unlicensed/Exempt Medicines
Refer to PSI Guidelines on the Sourcing of Medicinal Products for Sale or Supply by a Retail
Pharmacy Business, Section 3.2.3, Medicinal Products Exempted from the Requirement to
be Authorised – ‘Exempt’ Medicinal Products for further guidance
1. Receive a prescription for an unlicensed/exempt medicinal product

2. Ensure the prescriber is aware of the unlicensed/exempt status of the medicinal product. Discuss
with the prescriber any suitable authorised alternatives. Document the outcome of the conversation
and that the prescriber has been informed of the unlicensed/exempt status of the product in the
PMR
3. Order the unlicensed/exempt medicinal product from an authorised supplier as per SOP ODT 4:
Sourcing, Receiving and Storing Medicinal Products.
4. Use the ‘imply sent’ function on MPS to maintain stock-file accuracy
5. Label the prescription as per SOP DISP 2: Labelling a prescription
6. Assemble the prescription as per SOP DISP 3: Assembling a prescription
7. Complete clinical and accuracy check of the prescription as per SOP DISP 4: Completing a clinical
check of a prescription and SOP DISP 5: Completing an accuracy check of a prescription
8. Hand out the prescription as per SOP DISP 6: Handing out a prescription
9. Ensure that the patient is made aware of the unlicensed/exempt status of the product as part of the
patient counselling, and that it is recorded the PMR that the patient has been informed of the status
of the product
10. In addition to the statutory record keeping requirements for all prescription transactions, the
following additional requirements are required to be kept for unlicensed/exempt medicinal products
for a period of five years. This information should be recorded in the ‘item comment’ section of the
PMR:
• The supplier name for the product
• The name of patient supplied, the quantity supplied and the date of the supply
• The batch number of the batch from which the supply was made
• Details of any suspected adverse reactions
11. Store any broken bulk remaining of the unlicensed/exempt medicinal products in the designated area
of the dispensary for unlicensed/exempt medicinal products
12. Invoices and copies of prescriptions for unlicensed/exempt medicinal products should be stored in a
designated folder and retained for five years
DATE: Review due : 01/06/2025

SUPERINTENDENT PHARMACIST SIGNATURE:
01/06/2023 © Boots 2023
SOP:
DISP 11
Version 1
annually thereafter


Veterinary Prescriptions
This Standard Operating Procedure is for use when dispensing Veterinary Medicines in Community Pharmacy.
Pharmacists should refer to the Pharmaceutical Society of Ireland Advice on Animal Remedies (Veterinary
Medicines) when dispensing veterinary prescriptions.
The route of sale or supply and record-keeping requirements of an animal remedy depends on its category. The
classification or category can be readily identified as it is indicated on the labelling or outer packaging of the
product. If you are ever in doubt as to the classification of an animal remedy, information can be checked at
www.hpra.ie
1. Receive a prescription from a veterinary practitioner for the treatment of a small companion animal e.g. cat or
dog. Prescriptions for food producing animals e.g horse,cow should be received via the National Veterinary
Prescription Service (NVPS) which is currently unavailable in Boots Pharmacies.

2. Check the validity of the prescription.
Refer to Operational Guidance for the Requirements of a Valid Prescription
3. POM medicines should only be dispensed in line with the veterinary cascade. Please reference the Merck
Manual for supporting information.
4. A veterinary prescription for antimicrobials medicinal products is valid for five days from the date of its issue.
This is applicable to companion animals as well as food producing animals.
5. In circumstances where an emergency supply is requested by a veterinary practitioner, confirm the
circumstances of the emergency necessitating supply and that veterinary practitioner undertakes to provide a
prescription within 72 hours. Check that the requested medicine is not listed in Schedule 1 or 2 of the Misuse of
Drugs Regulations 1988, as amended.
Note that an emergency supply of a prescription only animal remedy at the request
of a member of the public is not permitted.
6. Label the prescription as per SOP DISP 2: Labelling a prescription. When entering the first name of the animal
patient, ensure to include the animal species in brackets (e.g. Sparkles (Cat) Murphy)
7. Assemble the prescription as per SOP DISP 3: Assembling a prescription
8. Complete clinical and accuracy check of the prescription as per SOP DISP 4: Completing a clinical check of a
prescription and SOP DISP 5: Completing an accuracy check of a prescription
9. Hand out the prescription as per SOP DISP 6: Handing out a prescription
10. A record of all purchases and sales of POM, POM(E), PS and LM animal remedies (both incoming and outgoing
transactions) must be maintained in the pharmacy. This is commonly known as a Veterinary Register. A record
of any human medicines supplied for use in animals must also be kept. It is not necessary to keep this record for
purchases and sales of companion animal medicines (CAM). The record in the Veterinary Register must contain:
• The date the transaction occurred
• The precise identity of the animal remedy (i.e. name, form, strength) or medicinal product
• The quantity received or supplied
• The name and address of the supplier or purchaser
• The manufacturer’s batch number of the product received/supplied, and
• Where the transaction relates to the supply of a prescription only medicine (POM), the serial number
of the veterinary prescription.
11. Where the prescription is fully dispensed, retain the original prescription in the pharmacy for five years. If the
prescription was partially dispensed, retain a copy (which could be a photocopy) of the prescription in the
pharmacy for five years. Attach a copy of the invoice for the medicine supplied to the prescription or copy and
retain with the prescription. A copy of the prescription should be given to the person presenting the
prescription, and the third copy will have been retained by the veterinary practitioner.
01/06/2023 © Boots 2023 SOP:
DISP 12
after receipt of SOP then Version 3
annually thereafter


Supply of Prescription Only Medication during the COVID-19
Pandemic
This Standard Operating Procedure (SOP) must be followed by Pharmacists and Dispensary team members
when dispensing medicines to ensure compliance with new, temporary amendments to the Medicinal
Products (Prescription and Control of Supply) Regulations 2003 (as amended) and the Misuse of Drugs
Regulations 2017 (as amended) as made by the Minister of Health.
This SOP is to be used in conjunction with existing Core Dispensing SOPs. Refer to the Guidance for prescribers
and pharmacists on legislation changes to facilitate the safe supply of medicines during the COVID-19
pandemic for further information, which is available at:
https://www.thepsi.ie/Libraries/COVID/Guidance_for_prescribers_and_pharmacists_on_legislation_changes_t
o_facilitate_the_safe_supply_of_medicines_during_the_COVID-19_pandemic.sflb.ashx
Electronic Transfer of Prescriptions
1. Ensure the prescription has been received through National Electronic Prescription Transfer System
(Healthmail)
2. To be legally valid the prescription must:
• be in electronic form
• be transmitted via Healthmail
• clearly indicate the date of issue
• clearly indicate the professional registration number of the prescriber
• be traceable electronically back to the prescriber
All other prescription requirements under the relevant legislation must still be met
3. For Schedule 2 or 3 Controlled Drug prescriptions the prescription writing requirements still apply,
however these do not need to be in the prescriber’s own handwriting.
4. The pharmacy must print a copy of the prescription as transmitted and treat it as an original prescription
for the purposes of record-keeping, reimbursement and also to assist with dispensing preparation and
checking. The printout, as well as an electronic version of the prescription must be retained for two years.
Refer to Operational Guidance on the use of Healthmail during COVID-19
Validity Period of Prescriptions
1. The maximum period of validity of a prescription for a human medicinal product is now 9 months from the
date specified on the prescription (previously 6 months).
2. For prescriptions that have been dispensed in full (marked with the word ‘dispensed’ and the date on
which it was dispensed), prior to the Covid-19 Emergency Provisions coming into force, the pharmacist
may make additional supplies against the prescription subject to the requirements for repeat dispensing
of S1A and S1B medicinal products. Previously once a prescription was dispensed in full no further
supplies were permitted using that prescription.
3. For Schedule 2 or 3 Controlled Drugs the validity remains unchanged (i.e. supply cannot be made later
than 14 days after the date on the prescription). Validity of prescriptions for a Schedule 2 or 3 Controlled
Drug to be dispensed in instalments is also unchanged i.e. the first instalment must be dispensed within
14 days of the date stated on the prescription and no instalment shall be supplied later than 2 months
after the date specified on the prescription.

Supply of Prescription Only Medication during the COVID-19 Pandemic
Repeat Supply
S1A Medicinal Products (S1A medicinal products are classified as ‘Non-renewable’ by the HPRA e.g.
antidepressants and hypnotics).
1. If the prescription does not state the number of repeats, nor the intervals that the medicinal product
may be supplied, S1A medicinal products can be dispensed on one additional occasion, where the
pharmacist considers it appropriate and necessary.
2. If the prescription is a health prescription (e.g. a GMS prescription), and is not endorsed to be repeated,
S1A medicinal products can be dispensed on no more than four occasions, where the pharmacist
considers it appropriate and necessary.

3. If the prescription states the intervals that a medicinal product can be supplied, but omits the number of
repeats, S1A medicinal products can be dispensed on no more than four occasions.
4. If the prescription states the number of repeats but omits the intervals, S1A medicinal products can be
dispensed, at such intervals that the pharmacist considers appropriate, having regard to the specified
dose rate and the maximum 9 month validity period of the prescription.
5. Where the number of repeats specified on the prescription has been reached, the prescription may be
dispensed on three further occasions, where the pharmacist considers it appropriate and necessary.
6. This excludes Controlled Drugs in Schedule 2 and 3; prescriptions for these medicinal products cannot be
repeated. It also excludes Schedule 4 Part 1 Controlled Drugs prescriptions; these can only be repeated if
specified by the prescriber
S1B Medicinal Products (S1B medicinal products are classified as ‘Renewable’ by the HPRA e.g. medicinal
products for chronic conditions including blood pressure, diabetes or asthma)
1. If the prescription does not state the number of repeats, nor the intervals that the medicinal product
may be supplied, S1B medicinal products can be dispensed for up to 9 months, on the number of
occasions that the pharmacist considers it appropriate and necessary.
2. If the prescription states the number of intervals that a product can be supplied but omits the number of
repeats, S1B medicinal products can be dispensed for up to 9 months, at the intervals stated on the
prescription.
3. If the prescription states the number of repeats but omits the intervals, S1B medicinal products can be
dispensed at such intervals that the pharmacist considers appropriate, having regard to the specified dose
rate and the maximum 9 month validity period of the prescription.
4. Where the number of repeats specified on the prescription has been reached, the prescription may be
dispensed on three further occasions, where the pharmacist considers it appropriate and necessary.
Record Keeping
1. If the prescription is unavailable (e.g. sent to PCRS for payment), the requirement to mark the prescription
with the quantity and date of supply of each medicinal product and the name and address of the
pharmacy does not apply.
2. In these circumstances the pharmacist must make a record of the reasons for making the supply under the
Covid-19 Emergency Provisions as part of the prescription register (i.e. daily audit report). This record
must be retained in the pharmacy for two years.
3. Where a prescription is received via Healthmail, the pharmacist must print the prescription as transmitted
and treat it as an original prescription for the purposes of record keeping. The printout, as well as an
electronic version of the prescription must be retained for two years.

Supply of Prescription Only Medication during the COVID-19 Pandemic
Emergency Supply
A. Emergency Supply at the request of the Patient

1. Under the Covid-19 Emergency Provisions, a pharmacist can dispense up to 10 days’ supply of a
prescription only medicinal product at the request of a patient.
All other emergency supply requirements under the relevant legislation must still be met
2. A pharmacist is permitted to supply a Schedule 2, 3 or 4 Controlled Drug at the request of a patient

where:
• It is unreasonable at the time of supply, in the circumstances arising from the Covid-19
emergency, for the person to obtain a new prescription for that medicinal product
• It is in the opinion of the pharmacist that it is safe, appropriate and necessary for the continued
treatment of the person for an emergency supply to be made, and
• No greater quantity of the product than will provide 5 days’ treatment is supplied.
• Up to 10 days’ supply can be provided of the following Schedule 4 Part 1 Controlled Drugs:
midazolam, clobazam and clonazepam for the treatment of epilepsy.
B. Emergency Supply at the request of the Prescriber

1. The existing requirements for the emergency supply of medication at the request of a prescriber remain.
2. Under the Covid-19 Emergency Provisions, a pharmacist can supply a Schedule 2, 3 or 4 Controlled Drug
at the request of a prescriber where:
• It is unreasonable at the time of supply, in the circumstances arising from the Covid-19
emergency, for the person to obtain a new prescription for that medicinal product.
• It is in the opinion of the pharmacist that it is safe, appropriate and necessary for the continued
treatment of the person for an emergency supply to be made, and
• No greater quantity of the product than will provide 5 days’ treatment is supplied.
• An emergency supply can be provided of the following Schedule 4 Part 1 Controlled Drugs:
midazolam, clobazam and clonazepam for the treatment of epilepsy. Legislation does not limit
the quantity of these drugs however, the pharmacist should be satisfied that the quantity
requested is safe and appropriate for the patient at that point in time.

01/06/2023 © Boots 2023 SOP:
DISP 13
Version 1
annually thereafter


How to Manage an Enquiry or Request for the Emergency Contraception
(EC) Service
This Standard Operating Procedure (SOP) must be followed by Pharmacists and

Responsible: Healthcare Team
Healthcare team members when they get a request for the Emergency
Contraception (EC) Service
1. When a patient requests or enquires about emergency contraception (EC) in the
pharmacy or by phone refer the patient to the pharmacist
• Always handle requests with discretion and sensitivity

Member
• If the pharmacist is busy give the patient an appropriate waiting time
2. Explain to the patient that the service includes a private consultation with a
pharmacist which will help establish whether they are eligible for the service
• Only women aged 17 years and over are eligible for this service
• Inform the patient of the cost of the service as appropriate
• If applicable, explain the chaperone policy
• Emergency Contraception is more effective the sooner it is taken
• Emergency Contraception cannot be supplied to a third party

• Advance supply of Emergency Contraception is not permitted
• If a patient had unprotected sex more than 120 hours earlier they are
not eligible for this service the pharmacist should refer to an
alternative service provider
SUPERINTENDENT PHARMACIST SIGNATURE: DATE:

01/06/2023
Review due : 01/6/2025
© Boots 2023
SOP:
EC1
SUPERVISING PHARMACIST SIGNATURE: DATE:
Audit due one month after
Version 10
receipt of SOP then
annually thereafter
Standard Operating Procedure (SOP) EC1 v10 Training Log
*Team Member: By signing this declaration you, the team member, are confirming that you have read,
understood and will comply with (i.e. follow) the SOP at all times
**Pharmacist: By signing this declaration you are confirming that the team member has received the
necessary training to follow the content of the SOP and you are satisfied that he/she is competent to
undertake the tasks identified within the SOP

How to Conduct a Consultation for the Emergency Contraception (EC)
Service
This Standard Operating Procedure (SOP) must be followed by Pharmacists when providing an
Emergency Contraception (EC) Service consultation for women aged 17 years and over
1. Greet the patient and bring them into the consultation room. Outline consultation process and
chaperone policy. Inform them of fee as relevant
• Be conscious of potential of non-consensual intercourse (e.g. rape/sexual assault),

child protection and vulnerable adult issues - refer to appropriate body, as relevant
• Provide details of the National 24-Hour Sexual Violence Helpline 1800 77 8888 for
additional support, where relevant
• Ensure information and contact details (including opening hours) for other EC service
providers and the nearest Rape Crisis Centre is available for reference in consultation
room & up to date
2. Complete Boots EC Consultation Record Form (CRF).

• Where not eligible for ulipristal 30mg or requests levonorgestrel 1500mcg note necessary
detail on CRF and complete levonorgestrel specific questions
• Where requesting a repeat supply of EC (only permitted due to vomiting within 3 hours of
taking a previous dose) note necessary detail on CRF and complete associated questions
3. Confirm patient’s eligibility based on responses and check if they have any questions
• If not eligible complete the relevant section of CRF noting the reason and advice given,
referring them to an alternative service provider, as appropriate and close consultation.
Complete any necessary GMS or HSE recording requirements – as per point 8
• If eligible provide patient with Boots EC Patient Advice leaflet. Guide them through the leaflet,
discussing ALL the points as detailed in Section 6 of the CRF. Obtain informed consent to
proceed with the service
• Always consult product SmPC and other up-to-date reference sources as
necessary to determine appropriateness of supply e.g. risk from contraceptive
failure, drug interactions, use in breast-feeding, adverse reactions,
contraindications
• Provide EC in line with any guidance provided by the Pharmaceutical Society of
Ireland (PSI) and also the PSI’s Code of Conduct for Pharmacists e.g. cannot be
provided to a third party or as advanced supply
4. Offer the patient the option of taking the medicine in the consultation room reminding them
that it’s more effective the sooner it’s taken. Provide the patient with a copy of the relevant
EC product Patient Information Leaflet (PIL)
5. Record supply on the dispensary computer system, the scheme to use will depend on claim
eligibility. Include ineligible consultations where Medical Card & HSE 17 to 26 years eligible
• For details on record keeping, payment, till process and claim processing refer to
Operational Guidance for the provision of Contraception Services

21/11/2022
Review due : 21/11/2024
© Boots 2022
SOP:
EC2
Version 13
receipt of SOP then
annually thereafter
Service (cont.)
6. Return to consultation room with medication and disposable cup of drinking water if taking
straight away and provide to the patient
7. For Private Emergency Contraception take payment through the till. For Free Contraceptive
Service Scheme scan the EC Service barcode or use the EC Service till button.
8. File paper CRFs in the Secure Record Holder (in chronological order). Remove EC Record
Forms on a monthly basis, store with other prescriptions and keep for 2 years
• If supply to a patient is likely to be affected by a pharmacist’s personal or moral

standards the Superintendent Pharmacist and Supervising Pharmacist must be
informed

21/11/2022
Review due : 21/11/2024
© Boots 2022
SOP:
EC2
Version 13
receipt of SOP then
annually thereafter
Standard Operating Procedure (SOP) EC2 V13 Training Log

Safe Supply of Oral Methotrexate
2. For every dispensing episode, the pharmacist must personally carry out a complete review of the
patient’s PMR which should include asking the patient about any over the counter medicines they might
be taking as well as prescribed medicines. It is good practice to record that you have conducted this
review on the PMR
3. Check with the patient that they are undertaking regular blood monitoring. You may wish to liaise with
the prescriber to establish the patient’s protocol so that you can check that the blood tests are in range at
the appropriate intervals. Quantities greater than one month should only be supplied in exceptional
circumstances
4. Conduct a clinical check of the prescription as per SOP DISP 4 Complete a Clinical Check of a Prescription
and if a query arises contact the prescriber for resolution.
• The dose should lie in the usual dose range 7.5mg-25mg orally once weekly: any
deviation from this, or the absence of an actual dosage instruction on the prescription,
should be directly confirmed/ queried with the prescriber.
• If the dosage on a prescription states a once daily dose, the pharmacist must always
query with the prescriber whether this is correct.
• When a prescription is issued the pharmacist should always confirm the indication for
prescribing, particularly when a prescription is issued by a non-hospital based prescriber.
5. The prescription should be labelled, assembled, clinically checked and accuracy checked as outlined in SOP
DISP 2-5. Gloves should always be used in the handling of methotrexate tablets outside of their packaging.
6. It is recommended that the dose be stated on the label in number of tablets, total dose, weekly interval
and day of the week on which it is to be taken i.e. Take six x 2.5mg tablets (15mg in total) once a week on
a Friday.
7. If the patient is prescribed folic acid, ensure that they are dispensed in packaging that allows them to be
easily identified from methotrexate e.g. use of highlighter pen, different sized bottles.
8. Upon collection, the pharmacist should personally supply the appropriately labelled medicine to the
patient/carer, and should verbally confirm the dosage requirements with the patient, reinforcing the
labelled instructions in a clear manner. A Patient Information Leaflet (PIL) should always be supplied. An
offer must be made to counsel the patient every time the patient receives methotrexate, and must always
be conducted for new patients. This should include advising the patient of:
• The importance of having regular blood tests
• The importance of safe storage to the patient in order to reduce the risk of inadvertent poisoning.
• Always informing other healthcare professionals that they are taking methotrexate
• Checking with a pharmacist before taking OTC medicines
• Reminding them to contact their doctor immediately if any signs of infection present e.g. sore
throat, mouth ulceration, unexplained rash, fever, chills, vaginal infections/ulceration
• The need for the use of reliable contraception during treatment with methotrexate and for six
months after cessation of treatment (both male and female patients of child-bearing age)
• Refer to PSI Guidance for Pharmacists on Safe Supply of Oral Methotrexate for further
information.
• This SOP is intended as a guide to best practice, and is not intended as a substitute for
pharmacists professional and clinical judgement

01/06/2023 © Boots 2023 SOP:
SUPERVISING PHARMACIST SIGNATURE: DATE: Audit due one month after
MED 1
receipt of SOP then annually
thereafter Version 1
Standard Operating Procedure (SOP) MED 1 V1 Training Log

Safe Supply of Sodium Valproate
2. For every dispensing episode, the pharmacist must personally carry out a complete review of the
patient’s PMR. It is good practice to record that you have conducted this review on the PMR
3. If the patient is a female child or woman of child bearing potential, valproate containing medicines must
only be prescribed and dispensed in accordance with the Valproate Pregnancy Prevention Programme. If
a query arises in this regard, contact the prescriber for resolution.
4. The prescription should be labelled, assembled, clinically checked and accuracy checked as outlined in SOP
DISP 2-5. Where possible, dispense the valproate containing medicine in the original packaging with the
manufacturer’s warning and including a patient information leaflet. If repackaging cannot be avoided,
ensure that the medication is accompanied by a copy of the patient information leaflet, and that a
Valproate warning label is applied to the packaging. Include a Valproate Patient Card with the dispensed
prescription.
• Epilim pharmacy materials including the Valproate Patient Card, the Valproate warning
sticker and a Valproate patient guide are available to order from Sanofi Medical
Information by telephone 01-4035600 or by email Iemedinfo@sanofi.com
• The Valproate Patient Guide and the Valproate Patient Card are also available to
download from www.hpra.ie
5. Upon collection, the pharmacist should personally supply the appropriately labelled medicine to the
patient/carer. In addition to the patient counselling provided for in SOP DISP 6: Hand out a prescription,
the following points should be highlighted to the patient:
• Every time a valproate medicine is dispensed to female children or women of child-bearing
potential, the patient should be reminded of the risks associated with the use of valproate during
pregnancy, and the consequent need to use effective contraception.
• Ensure that the patient has been provided with and understands the contents of the Valproate
Treatment Card.
• If a female patient of childbearing potential indicated she is not using effective contraception,
refer the patient to their GP.
• Offer to provide the patient with a copy of the Valproate Patient Guide.
• Remind the patient of the need for an annual specialist review.
• Refer to HSE Circular 006/18 and the HPRA information on valproate available from
http://www.hpra.ie/homepage/medicines/special-topics/valproate-(epilim)
• This SOP is intended as a guide to best practice, and is not intended as a substitute for
pharmacists professional and clinical judgement.
6. Valproate–containing medicines are subject to additional monitoring requirements and healthcare
professionals are requested to report any suspected adverse reactions associated with use to the HPRA

01/06/2023 © Boots 2023 SOP:
MED 2

Standard Operating Procedure (SOP) MED 2 V1 Training Log

Date checking of dispensary stock
• Date expired stock must be destroyed promptly and clearly segregated from other stock to
avoid any risk of this stock re-entering the supply chain
• Expired controlled drugs can only be disposed of by witnessed destruction – see SOP CD 4
Destruction of Schedule 2, Schedule 3 and Schedule 4 (CD2, CD3 and CD4) Controlled Drugs
• Pharmacy and healthcare risk waste must be destroyed by an authorised waste management
company, and must never enter the ordinary channels for domestic waste
A. Setting up the Dispensary Date Checking Matrix

1. Print a quarterly dispensary date checking matrix from BootsLive
2. Divide the dispensary into thirteen sections and record the details of each area in the column headed
“Area of dispensary”.
3. Record the week commencing dates for each week of the quarter in the row headed “Week commencing”
B. Completing the Weekly Date Checking

1. Identify the area of the dispensary to be date checked from the quarterly dispensary date checking matrix
2. Check the expiry date of each stock container in turn. Rotate stock in order of expiry date placing stock
with longest expiry date at the back.
3. Remove and quarantine expired medicines/items and any medicine/item which is within one month of its
expiry date (for calendar packs containing more than one month’s supply, consider removing earlier).
4. Identify any stock with an expiry date in the following four months, and mark with a short-dated stock
sticker. Record the identify of this stock on a Pharmacy Short-Dated stock form (available from BootsLive).
5. Annotate the dispensary date checking matrix with initials and date to confirm date checking has been
completed.
C. Monthly Date Checking Tasks

1. At the beginning of the month, retrieve the Pharmacy Short-Dated Stock Form for the next calendar
month.
2. Check the dispensary shelves for any stock listed on the form. Remove and quarantine awaiting
destruction any remaining items. Annotate form to confirm the short-dated stock has been removed.
D. Destruction of Quarantined Stock and Credit Claiming

1. Destroy stock quarantined following completion of weekly and monthly date checking tasks following SOP
ODT 2 Disposal of Pharmacy And Healthcare Risk Waste
2. Using the Stock Expired Programme in MPS, adjust the stock figures for all stock destroyed.

01/06/2023 © Boots 2023 SOP:
ODT 1
annually thereafter Version 2

Standard Operating Procedure (SOP) ODT 1 V2 Training Log

Sourcing Medicinal Products
1. Identify supplier for required medicinal product(s) and check that the supplier is on the list of authorised
suppliers of medicinal products overleaf. Place an order for the required medicinal product(s) as appropriate;
• Medicinal Products from United Drug, Uniphar and PCO may be ordered electronically using MPS.
• Unlicensed/Exempt Medicines and Specials may be ordered from Clinigen (previously QM Specials) as
our preferred supplier of all unlicensed medicines and specials.
Refer to ‘Clinigen Ireland Website Instructions’ on BootsLive
• For High Tech Medicines, check that the High Tech Medicine is listed in the relevant appendix on the
High Tech Hub for ordering. The User Guide and FAQ Documents are available under the help section
on the High Tech Hub application. The support team in the High Tech Co-ordination Unit can be
contacted via email at pcrs.hitech@hse.ie or by phone at 01-8647135. If you need to fax the unit. You
can do so at 01-8914899.
• For Medicinal Products that are not available from the authorised suppliers overleaf, please contact
the Pharmacy Team Administrator or Pharmacy Business Manager for further advice.
2. In the event that an order is placed by telephone, create an electronic order file by using the ‘imply sent’
function on MPS. This helps to maintain stock-file accuracy.
3. On receipt of the order from the authorised supplier, check that all medicinal products listed on the invoice are
received. Inform the pharmacist-on-duty and he supplier of any missing items, any items which were delivered
outside of the correct storage conditions, or any items which may have been damaged in transit. Request that
the appropriate credit note is issued.
4. Quarantine any defective stock, suspect counterfeit stock, or inappropriately authorised medicinal products
which have been received. Refer to SOP ODT 5 – Receiving and Storing Medicinal Products or contact the
Pharmacy Office for advice.
5. Follow SOP ODT 5 – Receiving and Storing Medicinal Products and ensure the stock-file is updated.
6. Retain the supplier invoices in a secure location for the required period.
Refer to ‘ROI - Pharmacy Document Retention Guidance’ on BootsLive
SUPERINTENDENT PHARMACIST SIGNATURE: Review due : 01/06/2025

DATE: 01/06/2023 © Boots 2023 SOP:
ODT 4
Sourcing Medicinal Products
List of Authorised Suppliers
Supplier Product Type Contact Store A/C Number
Dub: 01-4632300
Medicinal Products, ULMs,
United Drug Ballina: 096-72555
OTC Lines
Limerick: 061-315411
Medicinal Products, ULMs
Uniphar 01-4041600
(Pharmasource), OTC Lines
PCO Parallel Imports 01-8356700
Selected OTC Lines/Boots

Boots N/A
PA Licensed Medicines
Clinigen ULMs (Preferred) 058-72111
Medisource ULMs 01-2866366
Georgelle ULM – Hydrocortone 01-4513733
Selected Ostomy Products

Salts not supplied by 01-4600749
UD/Uniphar
www.freestylelibrepharma
Abbot Freestyle Libre Sensors
cyportal.ie
Dexcom Dexcom CGMs 1800 827 602
Selected High Tech

Pfizer Medicines not available via 1850 249 349
the High Tech Hub
Selected High Tech
Astellas Medicines not available via 01-637314
the High Tech Hub
Selected High Tech
HE Clissman Medicines not available via 01-4688700
the High Tech Hub


Receiving and Storing Medicinal Products
(Prescription and Non-Prescription Products)
Receiving and Storing Prescription Medicinal Products
1. Receive an order from an authorised supplier, and check that the number of outer packages you are
signing for matches the delivery documentation, and that all packages are for your pharmacy and have
Responsible: Pharmacist, Pharmacy Team Member, Delivery team member
intact supplier’s seals

2. Break the supplier’s seal on all outer packages in the presence of a pharmacist
3. Retrieve any fridge lines from the order, and place these in the pharmacy fridge immediately
4. If the order contains any controlled drugs, follow SOP CD 3 - Receiving a Schedule 2, 3 or 4 Part 1
Controlled Drug as appropriate
5. Check that all medicinal products listed on the supplier invoice have been received and are undamaged.
Inform the supplier of any missing items or items damaged in transit, and request that the appropriate
credit note is issued. Make a note on the invoice of any credit note requested
6. Isolate any ‘exempt’ medicinal products and high tech medicines so that these can be stored in the correct
area of the dispensary.
7. Begin putting the stock away, taking care to match the product name, strengths and forms with those on
the shelf
8. Place the products with the longest expiry date behind the stock with the shortest expiry date to ensure
effective stock rotation. Place the product on the shelf in a way that the product name strength and form
is clearly visible. Repeat this process until all the items received have been put to shelf.
9. Ensure that any packages that have been placed in the fridge are opened and put away in the correct
location in the fridge, so that products with the longest expiry date are placed behind the corresponding
stock with the shortest expiry date to ensure effective stock rotation. Place the product on the shelf in a
way that the product name, strength and form is clearly visible
10. Update the stock file following the procedures in the MPS manual to confirm receipt of the delivery
Receiving and Storing Non-Prescription Medicinal Products
1. Receive an order from an authorised supplier, and check that the number of outer packages you are
signing for matches the delivery documentation, and that all packages are for your pharmacy and have
intact supplier’s seals
2. Break the supplier’s seal on all outer packages in the presence of a pharmacist
3. Book in the delivery using the process outlined on BootsLive
4. Begin putting stock to shelf following the Model Day process
5. While retrieving medicinal products from the delivery, confirm that the medicinal products are licensed
for sale in Ireland
• Medicinal products licensed for sale in Ireland are marked with a PA number or an EU number on
their packaging
• Traditional herbal medicines licensed for sale in Ireland are marked with a TR number on their
packaging
• Homeopathic medicines licensed for sale in Ireland are marked with a HoR number on their
packaging
6. In the event that any doubt exists as to whether a medicinal product is licensed for sale in Ireland,
quarantine the stock and the associated delivery documentation and bring to the attention of the
pharmacist on duty
7. Begin putting the stock away following the planner layout. Take care to match the product name,
strengths and forms with those on the shelf
8. Place the products with the longest expiry date behind the stock with the shortest expiry date to ensure
effective stock rotation. Place the product on the shelf in a way that the product name strength and form
is clearly visible. Repeat this process until all the items received have been put to shelf
9. Put any excess stock away in the dedicated area of the stockroom for healthcare products

Receiving and Storing Medicinal Products
(Prescription and Non-Prescription Products)
Instructions for Quarantined Products

1. Review the packaging of the product to identify any licensing information

2. Contact the Pharmacy Office to confirm the status of the medicinal product concerned in Ireland in the
event it is unclear if the product is licensed for sale in Ireland
3. Put any authorised products to shelf in the normal way
4. For unauthorised products, contact the Regulatory Affairs Manager from the ROI Pharmacy Office. Details
of the identity of the unauthorised product, its license number, batch number and expiry date, and where
possible, the UOD number from the delivery container in which the unauthorised product was received.
5. Keep the product quarantined until further instruction to prevent sale of the product concerned.
6. Follow recall instructions provided to return quarantined stock to the relevant supplier
7. In the event instructions are received to destroy quarantined stock, destroy the quarantined stock
following the process set out in SOP ODT 2 - Disposal of pharmacy and healthcare risk waste (including
patient-returned medicines) ensuring to have the destruction witnessed by a colleague. Instructions to
destroy quarantined stock will only be provided in writing from the Pharmacy Office. Make an entry in a
dedicated note-book for recording destruction of unauthorised medicinal stock and confirm the
destruction of the unauthorised medicinal stock by email to the Pharmacy Office

1/06/2023 Review due : 01/06/2025
© Boots 2023 SOP:
ODT 5


Responsible: Pharmacist, Dispensary Team Member Dealing with a Recall or Withdrawal of a Medicinal Product
Recalled products must never re-enter the supply chain
1. Receive the product recall or withdrawal notice from the marketing authorisation holder, the HPRA or via a
BootsLive alert
2. Establish the level of recall (e.g. patient level, pharmacy level, wholesaler level).
3. Segregate any stock held which is subject to a product recall or withdrawal notice from general stock and store
this in a dedicated area until it can be returned. Follow the instructions on the product recall notice for return
of this stock
4. Make the necessary adjustments to the stock-file to ensure that stock-file accuracy is maintained
5. Notify all dispensary staff of the recall or withdrawal
6. For patient level recalls of dispensing stock, print a ‘dispensed drug’ report from MPS. Alert any affected
patients and their prescribers of the product recall or withdrawal as soon as possible. Agree an alternative
treatment strategy with the prescriber where appropriate
7. For patient level recalls of non-dispensing stock, display any recall notices in a prominent area of the pharmacy
8. Check the records for any stock that has been loaned to another pharmacy. Inform the borrowing pharmacy if
any of the affected stock has been loaned
9. Endorse the recall or withdrawal letter to indicate that the recall or withdrawal has been processed. Retain a
copy of the recall or withdrawal letter, copies of all associated returns paperwork, and a copy of the list of any
patients contacted in the pharmacy

01/06/2023 © Boots 2023 SOP:
ODT 6

*Team Member: By signing this declaration you, the team member, are confirming that you have read, understood and
will comply with (i.e. follow) the SOP at all times
**Pharmacist: By signing this declaration you are confirming that the team member has received the necessary training
to follow the content of the SOP and you are satisfied that he/she is competent to undertake the tasks identified within
the SOP
Inter-pharmacy exchange of Medicinal Products
• Inter-pharmacy exchange of medicinal products is only permitted to meet the immediate

prescription needs of an individual patient. Transfer of excess stock between pharmacies is not
permitted.
• Medicines must never be exchanged with pharmacies located outside the Republic of Ireland
• CD2 medicines must only be exchanged when there is no other available option. The format of the
requisition is as outlined in article 12 of the Misuse of Drugs Regulations, 1988
A. Borrowing Medicinal Products from another Pharmacy

1. Contact the closest pharmacy by telephone to establish if stock of the required medicine is available
2. Record details of the date of the inter-pharmacy exchange, the name of the medicinal product involved and its
batch number and expiry date, the quantity of medication borrowed, the supplier name (wholesaler or
manufacturer), the name of the lending and receiving pharmacy, and the reason for the exchange in a duplicate
book. This entry must be signed by the pharmacist. Details of the batch number, expiry date and supplier name
should be obtained from the lending pharmacy.
3. Send a representative to the lending pharmacy to collect the medicine with the duplicate book
4. Ask the pharmacist in the lending pharmacy to sign the duplicate book. Give the duplicate copy of the entry to
the pharmacist in the lending pharmacy
5. In the case of a CD2 medicine, the request must also be accompanied by a requisition which states the name
and address of the recipient pharmacist, the total quantity of medication required (in words and figures), the
purpose for which the medication is required and is signed by the recipient pharmacist. A copy of this
requisition must be retained. Enter details of the transaction in the CD register
6. Ensure that a sufficient quantity of the borrowed medicine is ordered to replace the borrowed medicine where
the medicine is borrowed from a pharmacy other than a Boots pharmacy, and to maintain sufficient stock levels
of this product in the future.
7. On receipt of the stock from the wholesaler, return the quantity of stock to the lending pharmacy which was
borrowed where this pharmacy is a non-Boots pharmacy. Update the duplicate book to indicate that the
borrowed stock has been returned. This entry should be countersigned by the pharmacist in the lending
pharmacy
B. Lending Medicinal Products to another Pharmacy

1. Confirm that the required stock is available to lend to the receiving pharmacy
2. Confirm the identity of any representative sent by the receiving pharmacy
3. Sign the documentation supplied by the receiving pharmacy and retain a copy of this documentation. If any of
the details required for borrowing stock as outlined in step 2 are omitted, add these details before proceeding.
4. In the event of lending a CD2 medicine, ensure that a requisition as described in step 5 is also supplied. Enter
details of the transaction in the CD register
5. On return of the stock, check to ensure that the required quantity has been returned. Update the
documentation received from the borrowing pharmacy to confirm return of the stock where the borrowing
pharmacy is not a Boots pharmacy

01/09/2021 © Boots 2021 SOP:
ODT 8

The Boots Healthcare Way: Protocol 1
Sale of Non-Prescription Medicines containing Codeine
The PSI have issued Guidance for Non-Prescription Medicinal Products Containing Codeine: Guidance for Pharmacists on the Safe Supply to
Patients, which is available at www.thepsi.ie This protocol should be used in conjunction with the PSI Guidance.
Greet the
Make the customer feel welcome and give them your undivided attention.
customer
Establish
Receive your customers named product request for a medicinal product containing Codeine.
Needs
• Explain to the customer you will need to ask some questions to make sure the product is safe
and suitable for them. Consider the use of the patient consultation area to optimise privacy.
• Based on the information already provided by the customer, ask additional questions so that
you can answer all of the WWHAM questions (i.e. if the customer has already indicated who
Deliver
the product is for, you do not need to ask, ‘Who is the medicine for?’)
patient-
• Consult with the pharmacist to determine the safety and suitability of the product
centred care
• If the pharmacist determines a codeine-containing medicine is safe and suitable, use the CARE
framework to explain the use of the product to the customer.
• If the pharmacist determines a codeine-containing medicine is not appropriate, the
pharmacist should politely explain the reason for non-supply to the customer and personally
discuss alternative treatment options with them.
• Give the customer additional help and advice to help manage their pain e.g. keeping a
Personalise
headache diary to identify triggers, staying hydrated.
additional
• Consider if additional ancillary products may be helpful to the patient e.g. a heat pad or muscle
advice
rub for muscular pain.
Inspire next • Show empathy & interest in the patient’s ongoing health and welfare.
visit and • Ask if the patient has any further questions and invite the customer to contact or return to the
close pharmacy for any additional advice they may need.
Counselling points to be addressed during counselling on the use of a non-prescription codeine containing medicine include the
following:
• Dose to be taken (consult the product information for correct information on individual products)
• Codeine containing medicines should be used for the shortest time possible and for no longer than three days without
medical supervision
• Potential side effects can include nausea, constipation, dizziness, drowsiness and tolerance
• Non-opioid analgesics, including paracetamol, aspirin and ibuprofen are appropriate first line treatments for pain
• Ensure the counselling includes all required advice on other ingredients containing in the medicine (e.g. combination
products of codeine and paracetamol)
• The risks associated with overdose and/or prolonged use should be addressed with the patient.
• If patients experience the need to use codeine medicines over a prolonged period of time (i.e. more than three days)
for pain relief or relief of another symptom, the patient should be referred to a medical practitioner who would be able
to review their symptoms and provide appropriate treatment under medical supervision.
• The need for safe storage of these medicines should also be addressed with patients
SUPERINTENDENT PHARMACIST SIGNATURE: DATE: Review due: 01/06/2025

01/06/2023
© Boots 2023 SOP: OTC 1
Protocol 1
annually thereafter
Sale of Non-Prescription Medicines containing Codeine
Standard Operating Procedure Boots Healthcare Way: Protocol 1 - Training Log
*Team Member: By signing this declaration you are confirming that you have read, understood and will comply with the SOP at all times
**Pharmacist: By signing this declaration you are confirming that the team member has received the necessary training to follow the content of the
SOP and you are satisfied that he/she is competent to undertake the tasks identified within the SOP
Sale of Non-Prescription Dovonex® Psoriasis Ointment
The PSI have issued Guidance on the Safe Supply of Dovonex® Psoriasis Ointment by Pharmacists, which is available at www.thepsi.ie
This protocol should be used in conjunction with the PSI Guidance.
Greet the
Make the customer feel welcome and give them your undivided attention
customer
Establish
Receive your customers named product request for Dovonex® Psoriasis Ointment
Needs
Deliver
patient-
centred care
• If the pharmacist determines Dovonex® Psoriasis Ointment is safe and suitable, use the CARE
framework to explain the use of the product to the customer
• If the pharmacist determines Dovonex® Psoriasis Ointment is not appropriate, the pharmacist
should politely explain the reason for non-supply to the customer and personally discuss
alternative treatment options with them
Personalise • Give the customer additional help and advice to help manage their symptoms of psoriasis e.g.
additional avoid fragranced products and detergents
advice • Consider if additional ancillary products may be helpful to the patient e.g. emollient therapy
Inspire next • Show interest in the patient’s ongoing health and welfare
visit and • Ask if the patient has any further questions, and invite the customer to contact or return to the
Counselling points to be addressed during counselling on the use of a non-prescription domperidone containing medicine
include the following:
• The correct application of Dovonex® Psoriasis ointment, highlighting that it shouldn’t be applied to the face, scalp,
flexures or genital area, and not just before a shower/bath. The patient should wash their hands after use.
• Emollients may be used alongside treatment or it may be used as a monotherapy.
• To not exceed the maximum weekly usage of 100g, or cover Dovonex® Psoriasis ointment with any type of occlusive
bandage, as this may increase the risk of hypercalcaemia.
• To see a doctor if the condition does not improve within 4 weeks of treatment, becomes worse at any time during
treatment, they develop more extensive skin or nail involvement, or they develop joint pains and/or swelling of joints.
• To avoid excessive exposure to either natural or artificial sunlight and avoid the use of UV lamps during treatment.
• If within 12 weeks the condition has cleared or is substantially improved and the patient is satisfied with the outcome,
the treatment can be stopped. The treatment can be restarted if psoriasis reappears.
• If a patient does not reach a satisfactory outcome (e.g. achieves less than 50% reduction in psoriasis) by 12 weeks, the
patient should be referred to a doctor for review.
• If the patient is using other psoriasis treatments, such as other topical products containing calcipotriol, topical
corticosteroids or topical retinoids, this product should only be used under the advice and supervision of a doctor.
• A review of the patient’s condition, by a doctor, should be done at least once a year.
• Dovonex® Psoriasis ointment is licensed to treat plaque psoriasis only, it should not be used on other forms of psoriasis.

01/06/2023 © Boots 2023 SOP: OTC 1
Protocol 3
annually thereafter
Sale of Non-Prescription Dovonex® Psoriasis Ointment
Sale of Sumatriptan 50mg Tablets
The PSI have issued Guidance for Pharmacists on the Safe Supply of Sumatriptan 50mg Tablets, which is available at www.thepsi.ie
This protocol should be used in conjunction with the PSI Guidance.
Greet the
customer
Establish
Receive your customers named product request for Sumatriptan 50mg Tablets
Needs
Deliver
patient-
centred care
• If the pharmacist determines that the supply of Sumatriptan 50mg Tablets is safe and suitable,
use the CARE framework to explain the use of the product to the customer
• If the pharmacist determines that the supply of Sumatriptan 50mg Tablets is not appropriate,
the pharmacist should politely explain the reason for non-supply to the customer and
personally discuss alternative treatment options with them
Personalise • Give the customer additional help and advice to help manage their symptoms of migraine e.g.
additional keeping a headache trigger diary, staying hydrated.
advice • Consider if additional ancillary products may be helpful to the patient e.g. tiger balm
Inspire next • Show empathy & interest in the patient’s ongoing health and welfare.
visit and • Ask if the patient has any further questions and invite the customer to contact or return to the
Counselling points to be addressed during counselling on the use of Sumatran Relief 50mg Tablets include the following:
• Sumatran Relief 50mg Tablets are licensed for acute treatment of migraine with or without aura in adults between 18
and 65 years, who have had a confirmed previous diagnosis of migraine and an established pattern of migraine.
• The recommended dose is one 50mg tablet at the onset of an attack. If symptoms improve but later reappear, a second
tablet may be taken two hours or more after the first dose. Maximum dose in 24 hours is 100mg. If symptoms do not
improve after the first dose, no second dose should be taken for the same attack– the migraine should be treated with
simple analgesics. Sumatran Relief is not to be used as prophylactic treatment.
• Sumatran Relief 50mg Tablets are not suitable for patients with allergies to sumatriptan or any other ingredients
contained in the tablets or to sulphonamide antibiotics, or patients with a history of seizures, heart conditions,
liver/kidney impairment or rare forms of migraine including hemiplegic, basilar or opthalmoplegic migraine.
• Patients reporting headaches which last longer than 24 hours, who experience more than 4 migraine attacks per month,
do not recover fully between attacks, have a pattern of migraine symptoms that has changed or whose attacks have
become more frequent, more persistent, or more severe should be referred to their doctor.
• Refer to pharmacist if patient is pregnant or breastfeeding, are taking any other medicines, are a heavy smoker, have any
risk factors or family history of early heart disease.
• If a patient experiences chest pain and tightness, advise them to stop taking the medication and consult with their doctor
or pharmacist. Refer to the package leaflet for a full list of potential side effects.

01/6/2023 © Boots 2023 SOP: OTC 1
Audit due one month
Protocol 4
SUPERVISING PHARMACIST SIGNATURE: DATE: after receipt of SOP then
Sale of Sumatriptan 50mg Tablets
Sale of Curanail® (Amorolfine) Medicated Nail Lacquer
The PSI have issued guidance on the safe supply of Curanail™ Medicated Nail Lacquer which is available from www.thepsi.ie. This protocol
should be used in conjunction with the PSI Guidance.
Greet the
customer
Establish
Receive your customers named product request for Curanail® Medicated Nail Lacquer
Needs
Deliver
patient-
centred care
• If the pharmacist determines that the supply of Curanail® Medicated Nail Lacquer is safe and
suitable, use the CARE framework to explain the use of the product to the customer
• If the pharmacist determines that the supply of Curanail® Medicated Nail Lacquer is not
appropriate, the pharmacist should politely explain the reason for non-supply to the customer
and personally discuss alternative treatment options with them
• Give the customer additional help and advice to help manage their condition e.g. wear
Personalise
breathable footwear, avoid prolonged wearing of boots and runners
additional
• Consider if additional ancillary products may be helpful to the patient e.g. anti-fungal powders
advice
and creams to treat concurrent skin infections
Inspire next • Show interest in the patient’s ongoing health and welfare
visit and • Ask if the patient has any further questions, and invite the customer to contact or return to the
Counselling points to be addressed during counselling on the use of Curanail® Medicated Nail Lacquer include the following:
• Curanail® Medicated Nail Lacquer is licensed for the treatment of mild fungal nail infections in adults affecting up to two
nails.
• Curanail® Medicated Nail Lacquer should be used once weekly. Refer to the package leaflet for full instructions for use.
Wash hands before and after use.
• Improvement in symptoms should be seen within three months, but it may take up to 6 months for an infection to clear
from a fingernail and up to 12 months for a toenail. Treatment should be continued until a healthy nail has grown back.
• Curanail® Medicated Nail Lacquer should not be used without advice from a doctor by patient suffering from diabetes,
immune system disorders or poor circulation to the hands and feet.
• Avoid the use of nail varnishes and artificial nails while undergoing treatment with Curanail® Medicated Nail Lacquer.

01/6/2023 © Boots 2023 SOP: OTC 1
Protocol 6
SUPERVISING PHARMACIST SIGNATURE: DATE: receipt of SOP then annually
Sale of Curanail® (Amorolfine) Medicated Nail Lacquer
Patient Journey through the Needle and Syringe Exchange
Service
This Standard Operating Procedure (SOP) must be followed by Pharmacists and Dispensary
team members* when providing the Needle and Syringe Exchange Service
1. Greet the patient and obtain the information required to claim payment for the service
2. For first time service users, ensure that they are over 18 years of age, are provided with
Responsible: Pharmacist, Dispensary Team Member*
information leaflets on safe injecting, overdose prevention and management and available
drug treatment services, and that they are aware of how to dispose of sharps and other
equipment safely
✓
Refer patients under 18 years old requesting needle exchange to local drug treatment
services
3. Ensure any used needles being returned are in a sharps container. If the used needles
presented for return are not in a sharps container provide the patient with a sharps
container to dispose of their sharps. Used needles returned in containers other than
sharps containers should be placed into an appropriately sized sharps container by the
patient
When in use the sharps collection bin must be stored in a secure location, inaccessible
to members of the public (e.g. within a locked bin cabinet which can only be opened
from the dispensary).
Full sharps bins awaiting collection must be sealed securely and stored in a location
inaccessible to the public e.g. dispensary
4. When accepting returns ask the patient to place their sealed sharps container into the
pharmacy sharps collection bin. This minimises the risk of accidental needle stick injury
Follow the “What to do in the event of a needle stick injury or accidental exposure to
blood” poster in the event of a needlestick injury
5. Give the patient sufficient safe injection packs and water for injection ampoules to meet
their needs
Do not restrict the number of safe injection packs provided to patients.
Do not split pre-packed safe injection packs.
Always check that the pre-packed safe injection packs in stock are in date.
Never handle any loose sharps or other used injecting equipment
6. Discuss any general health issues and, if appropriate, refer the patient to other healthcare
professionals

24/05/23
Review due : 24/05/2025
© Boots 2020
SOP:
NEX
Version 8
receipt of SOP then
annually thereafter
Patient Journey through the Needle and Syringe Exchange
Service (contd.)
7. If the patient does not have any sharps to return, do not refuse to supply safe injection packs
but encourage them to make returns in the future
8. Complete all necessary records of the needle exchange transaction using the MPS Services
Module under the patient “Needle Exchange”
Responsible: Pharmacist, Dispensary Team Member*
Consult the Operational Guidance for the Needle Exchange Service for further guidance
Any team member involved in the provision of the Needle Exchange Service is advised to
obtain a course of a Hepatitis B vaccination and must complete the declaration on the Boots
Hepatitis B Vaccination Record Status Form. This form will be stored in the employee’s
personnel file and the records maintained for 40 years. Guidance on how to avail of this
vaccine can be found on the Hepatitis B Vaccination Process document and further
information can be obtained from the Pharmacy Office Ireland.
* A needle exchange transaction may be delegated by exception to an authorised member

of the dispensary team (qualified assistant, trained dispenser or pharmacy intern ONLY) in
situations where the pharmacist is not immediately available, and the patient is NOT a first
time user of the service. Any patient who requires additional information about related
health matters e.g. injection technique, overdose prevention or asks for information about
access to drug treatment services MUST be referred to a pharmacist.

24/05/23
Review due : 24/05/2025
© Boots 2020
SOP:
NEX 1
Version 8
receipt of SOP then
annually thereafter
Standard Operating Procedure (SOP) Training Log

The Patient Journey through the
24 Hour Blood Pressure Monitoring Service
This Standard Operating Procedure (SOP) must be followed by Pharmacists and Pharmacy team
members when providing the 24 Hour Blood Pressure Monitoring Service
Patient request for the service

1. When a patient requests the 24 Hour Blood Pressure (BP) monitoring service check that they are
aged 18 years or over and eligible to join the service. Provide the patient with an overview of the
service and advise them of the fee
Responsible: Pharmacist, Pharmacy Team Member
2. Check availability of the Ambulatory Blood Pressure Monitoring (ABPM) device. Inform the patient
of the next available fitting appointment days and find an appointment that will suit them. Advise
the patient that it is recommended that the device is worn on a normal working day in order to
allow the best assessment of their blood pressure and that they don’t drive while wearing the
device
3. Book a Fitting Consultation appointment for the patient if they wish to proceed in the Appointments
Diary ensuring that an Authorised ABPM pharmacist will be working on the day that they need to
return the device, the day after the Fitting consultation
4. Advise the patient to wear a loose top, preferably a short–sleeved top (with loose sleeves), as the
monitor will be fitted on the upper arm, underneath it. If possible they should wear a belt to attach
the device to. Inform them that they won’t be able to have a bath or shower during the 24 hours
while wearing the device
5. Give the patient the 24 hour BP Service leaflet or refer to boots.ie for more information as relevant
• ABPM service is only provided to patients aged 18 years or older
• Information about the service is contained in the “About 24-hour blood pressure
monitoring” section of the service leaflet and also on boots.ie/blood-pressure-
monitoring-service page
• If the patient had a 24 hour BP measurement previously repeat measurements should
be performed on like days
• Always inform the patient that they must return device to the pharmacy after 24 hours
Patient reception
1. When the patient arrives for their fitting consultation, check patient in for their appointment in the
Appointment Diary, mark as Complete. Process the fee for the service through the till
2. Request them to complete Part 1 of the Patient Information section of the Consultation Record Form
(CRF) and then request the patient to wait in the consultation waiting area
3. Advise the ABPM Advisor that the patient is waiting for their appointment and give them the CRF,
with Part 1 completed
A patient may choose to complete Part 2 of the form but this will be checked during the
Fitting Consultation so any queries can be answered during that part of the consultation

01/06/2023 © Boots 2023 SOP:
ABPM 1
Version 7
receipt of SOP then
annually thereafter
The Patient Journey through the
24 Hour Blood Pressure Monitoring Service (contd.)
Device preparation for fitting consultation

1. Authorised ABPM Advisor to check all required information is completed in Part 1 of CRF
2. Change the batteries in the device and connect using USB cable to dispensary computer
3. Complete Part 1 of Pharmacy Only Use Section of CRF ensuring that all fields in this section are
completed
4. Programme device on dispensary computer via ‘ambulatory settings’ entering:
a) Patient ID reference number - create ID using patient’s initials and date of birth e.g. Joe Bloggs
17/05/45 Patient ID = JB170545

b) Set the other necessary information: Day period, Night period
c) “Setting Highest Inflation Pressure” tick Disable
d) “Setting Ambulatory Settings” ensure ‘Hiding BP data’ and ‘Silent Mode’ are ticked.
e) Save changes by clicking “Program”. Disconnect USB cable
5. Authorised ABPM Advisor to proceed as per SOP ABPM 2: Fitting Consultation as part of the 24
Hour BP Monitoring Service
• New batteries must be inserted for each fitting and battery indicator checked to ensure
status notes ‘normal’ each time the device is programmed for a new patient
• Standard day and night periods are 23:00 and 8:00 hours
• Standard measurement intervals are 30 minutes
• Recording intervals should be set to 30 minutes unless otherwise directed e.g. GP requests
15 minutes during day time hours
Results consultation
1. When a patient returns to the pharmacy after 24 hours, for their Results Consultation, ask the
patient for their name and the name of their ABPM Advisor (this should be written on the back of
the Patient Leaflet). Inform the ABPM Advisor that fitted the device that their patient has returned.
Inform the patient if delay expected
2. Guide the patient to the consultation waiting area and inform them that their Advisor will be with
them shortly
Microlife Afib 03 registration details

(required for validation of warranty & if communicating with Microlife Customer Services):
Device Serial Number:
Date of registration with Microlife:

01/06/2023
Review due : 01/0562025
© Boots 2023
SOP:
ABPM 1
Version 7
receipt of SOP then
annually thereafter
Standard Operating Procedure (SOP) Training Log ABPM 1 V7

Fitting Consultation as part of the 24 Hour Blood Pressure
Monitoring Service
This Standard Operating Procedure (SOP) must be followed by Pharmacists, Dispensary and Healthcare
team members when providing the fitting consultation as part of the 24 hour blood pressure
monitoring service
Consultation overview and consent

1. Authorised ABPM Advisor to bring box with device and equipment, and patient’s Consultation
Record Form (CRF) to Consultation Room
2. Greet patient and inform them of chaperone policy. Provide the patient with an overview of the
service, advising them that the consultation will take about 10-15 minutes
3. Check the patient’s details as provided in Part 1 of their CRF. Complete Part 2 of the form with the
patient, advising them that the answers to these questions will help the pharmacist assess their
blood pressure (BP) results more accurately
4. Provide patient with information from the leaflet covering “How will 24 hour monitoring help me”
, “What else will 24 hour monitoring look for?” and “What should I do during a measurement?”
5. Inform the patient about the need to keep a diary, providing an example of what that looks like,
referring to the table in the service leaflet
6. Obtain written informed consent, completing part 3 of CRF
If a patient is unsure of the answers to questions in Part 2 of the CRF, make a note on the
form and advise the patient that the pharmacist will go through the questions with them
when they return with device for their results consultation
Fitting the device

1. Ask the patient for permission to measure their height and weight. Where verbal consent provided
proceed to take measurements as per SOP BMI 1 calculation. Record the measurements on CRF
2. Check which arm is the patient’s dominant arm. Measure the circumference of the patient’s non-
dominant arm & select the cuff based on this arm size. Note this measurement on CRF
3. Advise the patient that you will take two test BP measurements, one on each arm
4. Set device to Casual mode and take a measurement on dominant arm. Record the results on the
CRF
5. Whilst the device is taking the BP measurement, remind the patient of the information covered in
“What should I do during a measurement?” and “Is there anything else I need to know?”
• The test or ‘casual‘ BP readings will ensure the patient is comfortable with the cuff
inflation and to check the BP readings are measuring correctly
• If a casual BP reading is 180/110mmHg or above refer to the on-duty pharmacist
• If there is a significant difference in blood pressure of more than 20/10mmHg the arm
that yields the highest reading should be used for the 24 hour measurements
• If a patient has fragile skin, arm injury, or lymphoedema the other arm should be
chosen for wearing the ABPM device e.g. dominant
• Ensure the correct cuff size is fitted as per arm circumference

01/06/2023
Review due :01/06/25
© Boots 2023
SOP:
ABPM 2
Version 7
receipt of SOP then
annually thereafter
Fitting Consultation as part of the 24 Hour Blood Pressure
Monitoring Service (contd.)
Fitting the device continued

1. Take the second BP measurement, fitting cuff barrier underneath ensuring neatly fitted. Record the
results on CRF
2. Leave this cuff in place for 24 hour recording on non-dominant arm (unless significant difference i.e.
>20/10mmHg in blood pressure between arms or patient has fragile skin, injury or lymphoedema).
Remove tight fitting jewellery from this arm, as relevant. Set device to Ambulatory mode
3. Inform the patient that the device will be worn on their upper arm for 24 hours, with the tube
connected upwards around the back of their neck and attached to the device that they will wear in a
pouch attached to sling around neck or belt. Show the patient how to disconnect the cuff tubing
from the device
4. Fit device to patient using straps provided. Record date, arm and time monitor was fitted on CRF.
Advise patient how to set up device at night. Ensure to anchor device in place e.g. connect to belt
• Ensure that cuff is fitted comfortably and securely, but not too tight
• Ensure to change the mode to ambulatory on the device before the patient leaves
• Check medication with the on-duty pharmacist as relevant
Closing the fitting consultation
1. Keep the CRF. Give the patient the Service Leaflet, reminding them to complete their diary and to
remember to bring it back in with them when they return the device. Make a note of the pharmacy’s
phone number and Advisor name on the back page of leaflet. Advise the patient that wearing the
device should not cause pain but if they experience pain they should switch the device setting from
ambulatory to casual and contact the pharmacy as soon as practical. Reminding patient again to
remain completely still during measurements, not to talk & keep arm at heart height
2. Inform the patient of the return time to the pharmacy, in 24 hours, to have the device removed and
to attend their Results Consultation with the pharmacist. Confirm the time will suit the patient. Close
consultation with the patient
3. Store the CRF in the ABPM record holder in the section – awaiting results consultation
Ensure to advise the patient:
• To keep their arm completely still when the device is taking a measurement so that as
many valid readings as possible are taken within the 24 hours
• Show the patient the button to press when they take blood pressure medication
✓ • That it’s recommended they don’t drive
• To avoid showering and bathing
• Not to exercise rigorously
• Not to turn off the ABPM device unless they experience pain
• To continue to wear the device at night but no need to make any record in the diary
• That at night to place the pouch (with device) safely on bed/locker the same side as the
arm with the cuff

01/06/23
Review due : 01/06/2023
© Boots 2023
SOP:
ABPM 2
Version 7
receipt of SOP then
annually thereafter

Results Consultation as part of the 24 Hour Blood Pressure
Monitoring Service
team members when providing the results consultation as part of the 24 Hour Blood Pressure
Monitoring Service
Device removal
1. When informed that patient has returned for results consultation trained Advisor go to the patient,
bring them into the consultation room. Provide overview of results consultation process and remind
them of chaperone policy
2. Request the Patient Leaflet and check that the diary has been completed including their asleep and
awake times, requesting the sleep times if absent, and other relevant information
3. Retrieve the device from the patient. Explain process for removing device and with their consent
detach the device and associated kit. Inform the patient that the results from the device will now be
downloaded onto a computer, following which the pharmacist will come to talk to them
• Ideally the ABPM Advisor who fitted the device should remove the device
✓ • Ensure to obtain verbal consent to remove the device
• If a patient has removed the device themselves, collect device & associated kit
Generating results report

1. Trained Advisor to return to dispensary with device. Locate the correct Consultation Record Form
(CRF) for the patient in the Ambulatory Blood Pressure Monitoring or ABPM folder
2. Connect the USB cable to the device and the dispensary computer. Click on ‘report settings’ and
enter the relevant patient details, double checking that the information is recorded accurately,
including the Patient ID, Patient Information i.e. Name, DOB, Sex and Doctor’s name.
3. Enter the awake and asleep time as per patient diary, taking extreme care that awake and asleep
times entered correctly. Tick ‘ABPM report’ and ‘hide error message’, then click OK
• Where a patient does not provide a doctor’s name record Pharmacy in the space provided
• Take extreme care that awake and asleep times entered correctly. If the times are entered
✓ incorrectly, the generated report will be invalid
• “hiding error message” can be unticked if the patient is complained of difficulties with the
machine
4. Download the data onto the computer and generate report keeping it open on the screen. Inform
the pharmacist that the report is ready for review
5. Wipe the tubing and device with an azo-wipe. Return the Blood Pressure (BP) monitoring device
and equipment to its storage box
Wash the BP cuffs at intervals according to manufacturer’s instructions and when visibly
dirty

01/06/2023
Review due : 01/06/2025
© Boots 2023
SOP:
ABPM 3
Version 7
receipt of SOP then
annually thereafter
Results Consultation as part of the 24 Hour Blood Pressure
Monitoring Service (contd.)
Pharmacist results evaluation

1. Pharmacist to review the generated report against information provided by the patient on their CRF
and check that all patient details are entered accurately and that graph correctly presents the
patient’s awake and asleep times. If patient is taking BP medication double check that the pill button
times noted on the graph match times in diary. Ensure sufficient readings are obtained, minimum 20
per day and 7 at night
2. Review the comment generated by the device and amend accordingly based on the results obtained.
Include pharmacist name, PSI number, pharmacy name and contact number on form. Print 3 copies in
colour. Keep device connected to the computer
3. Staple one copy of the BP monitoring printout to the CRF
• Always review results in association with presenting patient’s medical information

• If insufficient no of readings determine if necessary to repeat the 24 hour measurement
• Where threshold of 15% or more Afib readings noted and patient aged ≥ 50 years
and/or CVD risk then further test recommended to determine rhythm abnormality
• False positive Afib readings can occur due to movement during measurement and are
also common in young people due to ectopic beats
• If the ABPM report indicates significantly raised readings the patient must be advised to
see a doctor within a short timeframe
• Threshold values for BP and Afib readings used by the Microlife Device are included on
the Doctor Information letter
• Blood Pressure threshold settings on device are:
o Day Sys = 135 & Day Dia = 85
o Night Sys = 120 & Night Dia = 70
Pharmacist results consultation

1. Bring the Consultation Record Form, Patient Leaflet, Doctor Information Letter and the other two
copies of the BP printout to the consultation room
2. Greet the patent in consultation room, introducing yourself and your role
3. Discuss the results with the patient, providing relevant information and advice and check if they have
any questions. Refer them to their GP as relevant
4. Provide the patient with two copies of the BP printout, one for their own records and one to provide
to their doctor at their next visit, attached to the Doctor Information Letter
5. Date and sign the CRF and close the consultation
6. Give CRF to ABPM Advisor & authorise to clear data from device
Device data clearing and record keeping
1. ABPM Advisor to clear the data from the ABPM device and remove the batteries. Record ABPM entry
for this patient in dispensary computer Services Module
2. Store the CRF (with BP printout attached) in chronological order, in the ABPM secure record holder
and keep for 2 years. Empty download folder on computer before close of business to ensure to
delete any digital records

01/06/2023
Review due : 01/06/2025
© Boots 2023
SOP:
ABPM 3
Version 7
receipt of SOP then
annually thereafter

How to determine a patient’s Body Mass Index (BMI)
This Standard Operating Procedure (SOP) must be followed by Pharmacy Team Members when
determining a patient’s Body Mass Index (BMI)
Process if using BMI machine (electronic device that automatically calculates BMI)
1. Explain the process to the patient and take them to the BMI machine
2. Ask patient to remove outdoor wear/bulky clothing and shoes
3. Follow instructions on BMI machine to obtain patient’s BMI
Process if using weighing scales

1. Where a BMI machine is not available, use weighing scales to obtain patient’s weight. Ask patient
to remove outdoor wear/bulky clothing and shoes. Make a note of the patient’s weight in kilograms
2. Measure patient’s height using appropriate equipment (e.g. Leicester Height Measure) and make
note of the patient’s height in meters
3. Calculate BMI using kg/m2 or BMI wheel
It is preferable that the patient wears socks for measuring and weighing, if this is not the
✓ case, place a sheet of paper on the weighing scales and height measure platform
Providing patient results

1. Provide record of weight, height and BMI (preferably printed from BMI machine) to customer
2. Provide customer with information on maintaining a healthy BMI
• Leaflets on healthy eating & exercise are available to order from www.healthpromotion.ie
• Guidance on healthy lifestyle can be found on www.hse.ie and www.boots.ie
Body Mass Index (BMI) Interpretation table**

BMI (kg/m2) Score Classification and advice
Less than 18.5 Lean BMI, indicating low body fat. However a low BMI can indicate weight is
too low which may lower immunity to disease. If BMI and body weight low,
may want to consider gaining increased muscle
Between 18.5 and 24.9 “Healthy weight” – patient should aim to stay within this range
Between 25 and 29.9 “Overweight” – patient should aim to lose some weight or at least prevent
any further weight gain
Between 30 and 34.9 “Obese” – losing weight will improve your patient’s health
More than or equal to “Very obese” – losing weight will significantly improve your patient’s health.
35.0 Further support may be required
** For all patients except those of South Asian descent
For patients of South Asian descent, a healthy weight range is a BMI score between 18.5 and 22.9; a BMI
score under 18.5 is classified as underweight; a BMI score between 23.0 and 24.9 is considered overweight; a
BMI score between 25.0 and 34.9 is regarded as obese and a BMI score above 35.0 is classified as very obese1
1Weight Management Treatment Algorithm A Quick Reference Guide for Primary Care July 2011 HSE ICGP

01/06/23
Review due : 01/06/2025
© Boots 2023
SOP:
BMI 1
V1
SUPERVISING PHARMACIST SIGNATURE: DATE: receipt of SOP then annually
thereafter

Standard Operating Procedure (SOP) BMI1 V1 Training Log

Blood Pressure Measurement
team members when taking a patient’s casual blood pressure measurement using
Boots Pharmaceuticals Advanced Blood Pressure monitor with AFIB alert
Patient reception
1. When a patient requests a Blood Pressure (BP) measurement take them into the consultation room
2. Provide them with the Blood Pressure Measurement Consultation Record Form (CRF) and ask them
to complete the patient information in part 1. Ask them to remove any bulky upper layers and
advise them that a trained Advisor will be with them shortly
3. Inform a trained advisor that patient is in consultation room waiting on BP measurement
• Patient should sit & relax for 5 minutes before BP measurement is taken
✓ • It is not necessary to remove a thin shirt /top as the device can detect blood pressure
through thin layers of clothing
Taking the blood pressure measurement
1. Trained advisor to collect blood pressure device as necessary and go to consultation room. Introduce
yourself and inform patient of chaperone policy.
2. Check patient’s information recorded on part 1 of CRF. Explain the procedure to the patient and
obtain their informed consent to take the measurement, completing part 2 of CRF
• To set up BP device connect the air tube from the cuff securely into the cuff socket on the
monitor and check set to ‘usual’ reading mode
• The cuff supplied with the BP device has a size range of 22cm-42cm
• Ensure the patient’s upper arm size is within the size range arrows noted on the cuff
• Refer to monitor instruction manual for further information on correct cuff fitting, icons,
error messages and trouble shooting
3. Set up the device to take a measurement. Proceed to wrap the cuff around the patient’s upper arm,
which when fitted should be level with the heart. Ensure bottom of the cuff is 2-3cm above the inner
fold of the elbow, with the ‘artery mark’ arrow on the cuff centred on the inside of the arm. Check
cuff fits comfortably and fastens firmly but does not pinch the arm
4. Check patient seated comfortably with their feet flat on the floor. Request them to relax their arm
and rest it on the table. Ask them not to talk or move whilst the cuff is inflating or deflating and that
it will take 3 measurements, with a short break (15 seconds) between each measurement. Press the
start button once
Factors that can affect BP measurement include patient:

• Is anxious or nervous
• Is a smoker who has smoked in the last 30 minutes
• Had caffeine in the last 30 minutes
• Regularly drinks more than 3 Standard Drinks of alcohol daily

Blood Pressure Measurement (contd.)
Results recording
1. Record the measurement noted on the display (average of the 3 readings) and other necessary
details in part 3 of the CRF. Where necessary, remove cuff from the patient’s arm and repeat
procedure after 5 minutes on other arm, recording measurement on part 3 of CRF e.g. unexpected
high or low reading
2. If AFIB icon displayed, indicating irregular heartbeat detected, and patient aged 50 or over
recommend a repeat measurement in 1 hour
• Only use to screen for irregular heartbeat in patients over 50 years. If AFIB icon is
displayed, repeat the measurement ideally 1 hour later and:
o If 2nd reading shows AFIB icon refer to their doctor within the next week for
further test, to determine the exact rhythm abnormality
o If 2nd reading does not show the AFIB icon then the previous abnormal reading
may have been due to transient irregular heartbeat
• Not recommended to screen irregular heartbeat in young people under 50 years due to
high prevalence of false positive AFIB alert readings.
• Arm movement during BP measurement can cause a false positive AFIB reading
Results interpretation
1. Pharmacist to consult blood pressure interpretation table and using the highest reading obtained,
give appropriate advice. If AFIB icon displayed interpret reading & provide necessary advice. Refer
patient to doctor as appropriate. Record advice given in part 4 of CRF.
2. Provide patient with top copy of the CRF and retain duplicate copy
Blood pressure reading interpretation table
BP reading (mmHg) Category Interpretation and advice

Less than 100/50 Low blood If patient feels well, referral unnecessary. If heart condition is suspected &
pressure customer is unwell, refer to GP
Between 100/50 and/or 129/84 Normal BP in normal range, review in 1 year
Between 130/85 and/or 139/89 High normal BP in upper range of normal, measurement is acceptable but on high side,
give lifestyle advice and recommend customer see GP in 1 year
Between 140/90 and/or 159/99 Grade 1 BP is raised. Give lifestyle advice and advise customer to see GP within the
hypertension next month
Between 160/100 and/or Grade 2 BP is raised. Give lifestyle advice and advise customer to see GP within the
179/109 hypertension next week
Greater or equal to 180/110 Grade 3 BP is significantly raised, remove cuff, record result and advise the customer
hypertension to visit their GP as soon as possible as this must be treated promptly
Note: The BP category is defined by the highest level of BP reading. Reference: Guidelines for taking blood
pressure outside the clinical setting August 2008 Irish Heart Foundation & 2013 ESH/ESC Guidelines for the
management of arterial hypertension)
• Replace device every 2 years (order code 63-78-544)
• Large cuff size can be ordered from My Purchasing – order code: MED63520
• Store the consultation record form in a Secure Record Holder and keep for 2 years
01/06/2023
Review due : 01/06/2025 SOP:
© Boots 2023
BP1
Audit due one month after Version 1
thereafter

Standard Operating Procedure (SOP) Training Log BP1 V1

Dispensing a Schedule 2, 3 or 4 Part 1 Controlled Drug
from a Prescription
A. Dispensing a Controlled Drug Prescription [Dispensary Team Member]
1. On receipt of a prescription for a Schedule 2, 3 or 4 Part 1 controlled drug, check that the prescription is in
date and meets all legal requirements.
2. If the prescription does not meet all legal requirements, refer to the pharmacist for further action,
ensuring that the patient is informed of any possible delay.
3. Label and assemble the CD medicine(s) following SOP DISP 2 Label a Prescription and SOP DISP 3 Assemble
a Prescription. For CD2 or CD3 medicines, request the CD safe key from the pharmacist to obtain the
required stock from the CD safe.
4. Pass the assembled prescription to the pharmacist for completion of the clinical assessment and accuracy
check of the prescription.
B. Checking, supplying and record-keeping for Controlled Drug Prescriptions [Pharmacist]

5. Complete a clinical assessment and accuracy check of the prescription following SOP DISP 4 Complete a
Clinical Assessment of a Prescription and SOP DISP 5 Complete an Accuracy Check of a Prescription.
6. Store any checked CD2 or CD3 medicines for collection in the CD safe in a bag labelled with the patient’s
name and address.
7. At the time of collection, unless they are already known to you, ask the person collecting the controlled
drug for proof of identification and their relationship to the patient if they are not the patient.
8. Hand out the prescription as per SOP 6 Hand out a Prescription.
9. For CD2 medicines, make an entry in the controlled drugs register in respect of the supply and update the
running balance.
Refer to Operational Guidance for the Management of Controlled Drugs
10. Retain the original prescription in the pharmacy for all Schedule 2 and 3 controlled drugs. For Schedule 4
Part 1 medicines, retain the original prescription in the pharmacy unless the prescription is repeatable, in
which case a copy of both sides of the prescription must be retained.

01/06/2023 © Boots 2023 SOP:
CD 1

Standard Operating Procedure (SOP) CD 1 V2 Training Log

Dispensing a Schedule 2, 3 or 4 Part 1 Controlled Drug
from a Requisition
A. Dispensing a Controlled Drug Requisition [Dispensary Team Member]
1. Receive a requisition from an authorised recipient for a Schedule 2,3 or 4 Part 1 controlled drug or an
urgent request for the supply of such controlled drug from a registered medical practitioner, registered
dentist, registered veterinary surgeon or registered nurse or midwife.
2. Confirm that the requisition meets all legal requirements and is accompanied by a signed statement from
a medical practitioner where this is necessary.
3. If the requisition does not meet all legal requirements, refer to the pharmacist for further action.
4. Label and assemble the CD medicine(s) following SOP DISP 2 Label a Prescription and SOP DISP 3 Assemble
a Prescription. For CD2 or CD3 medicines, request the CD safe key from the pharmacist to obtain the
required stock from the CD safe.
5. Pass the assembled requisition to the pharmacist for completion of the clinical assessment and accuracy
check of the requisition.
B. Checking, supplying and record-keeping for Controlled Drug Requisitions [Pharmacist]

6. Complete a clinical assessment and accuracy check of the requisition following SOP DISP 4 Complete a
Clinical Assessment of a Prescription and SOP DISP 5 Complete an Accuracy Check of a Prescription.
7. Store any checked CD2 or CD3 medicines for later collection in the CD safe in a bag labelled with the
authorised recipient’s name and address.
8. On request for collection, confirm that the person collecting the medication is the authorised recipient., or
that the person has been given written authority by the authorised recipient to collect the medication. In
the event the requisition is being supplied on foot of an urgent request from a registered medical
practitioner, registered dentist, registered veterinary surgeon, or registered nurse or midwife, remind
them of the requirement to provide a signed requisition within 24 hours. Hand out the requisition as per
SOP 6 Hand out a Prescription.
9. For CD2 medicines, make an entry in the controlled drugs register.
10. Retain the original requisition in the pharmacy for a period of two years.

01/06/2023 © Boots 2023 SOP:
CD 2


Receiving a Schedule 2, 3 or 4 Part 1 Controlled Drug
1. Receive a delivery containing a Schedule 2, 3 or 4 Part 1 controlled drug from an authorised wholesaler.
Confirm that packages received containing controlled drugs are sealed and intact, and that these packages
are intended for your pharmacy.
2. Open the delivery package and check that the contents of the package correspond with the controlled
drug items listed on the invoice / delivery note. Confirm that the stock received is in date and that any
tamper evidence seals are intact.
3. Sign the controlled drug receipt form provided by the authorised wholesaler and mark with the date of
delivery. In the event of any discrepancy between the stock received and the stock listed on the receipt
form or the receipt of damaged stock, annotate the controlled drugs receipt form with this information
and notify the wholesaler of the discrepancy.
4. Return the signed controlled drug receipt form to the authorised wholesaler within 3 working days of
receipt of the controlled drugs.
5. Store all Schedule 2 and 3 controlled drugs in the CD safe as soon as they are received. Store all Schedule
4 Part 1 controlled drugs in the correct location in the A-Z storage area in the dispensary. All stock should
be stored in a manner which ensures stock with the shortest expiry date is used first.
6. For Schedule 2 controlled drugs, make an entry in the controlled drugs register in respect of the receipt
and update the running balance.
7. Retain invoices in respect of the receipt of controlled drugs for a period of 2 years.

01/06/2023 © Boots 2023 SOP:
CD 3


Destroying a Schedule 2, 3 or 4 Controlled Drug
The destruction of controlled drugs, which are patient returns, date expired stock, obsolete or
damaged stock must be witnessed and recorded in the pharmacy. Further detail can be found in
the Operational Guidance for the Management of Controlled Drugs.
What schedule is the controlled drug for destruction?
CD2 CD3 CD4
Date expired, Patient returns Patient returns, date expired, obsolete or

obsolete or damaged stock
damaged stock
Make an entry in the CD destruction record book of the

Segregate the stock in the CD safe details of the stock for destruction. Segregate the stock
labelled as “expired / damaged in the CD safe labelled as “patient returns not for use”
stock awaiting destruction” or “expired/damaged stock awaiting destruction” as
appropriate
Contact an authorised witness to

arrange a date and time for Wearing personal protective equipment, destroy the
witnessed destruction stock using a DOOM kit following the instructions on
the kit in the presence of a trained member of the
dispensary team
Wearing personal protective
equipment, destroy the stock
using a DOOM kit following the
Update the CD destruction record book with the
instructions on the kit in the
method of destruction, the pharmacist’s signature and
presence of an authorised
the name and signature of the person who witnessed
witness
the destruction
Update the running balance in

the CD register, and make an
entry in the Witnessed
Destruction of Schedule 2
Controlled Drugs section of the
CD register

01/06/2023 © Boots 2023 SOP:
SUPERVISING PHARMACIST SIGNATURE: Audit due one month
CD 4
DATE:


Completing a Balance Check for a Schedule 2 Controlled Drug
• Balance Checks must be completed for Methadone and Suboxone once weekly
• Balance Checks must be completed once per month for all other Schedule 2 Controlled Drugs
1. Complete a balance check for each CD2 medicine, ideally prior to any dispensing activity for that day as
per the schedule outlined above.
2. Calculate the total volume/quantity (including any date-expired stock or obsolete/damaged stock
awaiting destruction) of each CD2 medicine physically present in the CD safe. For manufacturer’s sealed
original packs, take the declared volume/quantity on pack as the actual volume/quantity. For opened
containers, measure the volume/quantity using a graduated cylinder or other appropriate counting
device.
3. Record the physical volume/quantity present in running balance column of the CD register on the
relevant page with the description “Balance Checked and Verified by [Name of Pharmacist, Date]” for
each CD2 medicine.
4. In the event of a discrepancy between the running balance and the actual volume/quantity present, ask
another member of the pharmacy team to verify the physical volume/quantity present independently.
5. If the discrepancy is confirmed, check that all entries since the most recent balance check have been
made correctly.
Refer to:
• Operational Guidance on the Management of Controlled Drugs
• Controlled Drug Discrepancy Process Map
6. If the discrepancy can be resolved, make an amendment to the CD register by marginal note or footnote
to correct the error identified. Sign and date the amendment.
7. For methadone only, if the discrepancy is an overage of an acceptable volume based on the volume of
methadone dispensed, annotate the balance check by way of marginal note or footnote as resolved due
to acceptable manufacturer’s overage.
8. For all other unresolved discrepancies, complete a report of a controlled drugs discrepancy using PIERS.
Annotate the CD register with the incident reference number from PIERS.
Refer to PIERS for Pharmacy Teams – An overview of the reporting process available
on BootsLive and PIERS eLearning for Pharmacy Teams (ROI) for instructions on the
use of PIERS

01/06/2023 © Boots 2023 SOP:
CD 5
DATE:
annually thereafter
Version 3


Labelling and Assembly of a Controlled Drug Instalment Prescription
(e.g. Methadone, Suboxone)
Pre-dispensing Administration
1. Identify all patients due instalments and retrieve their prescription from the relevant folder
2. Identify any patients who may have missed an instalment from the day(s) previously and alert the
pharmacist on duty, in order that their prescriber may be contacted if necessary.
Prescriptions should be stored in a folder, in alphabetical order, with a copy of the patient’s
current valid Drug Treatment Card.
Assembly Process
Prescriptions for methadone and Suboxone™ prescribed for the treatment of opiate
dependence must be written on an opioid substitution prescription form issued by the HSE
Responsible: Pharmacist, Dispenser
1. Follow SOP 2 and 3 to label and assemble a prescription. When entering the prescription details on MPS,
ensure that the full dosage instructions are specified - the dose, supervised/take-away, and the date the
dose is due, i.e. ‘Take X ml/tablets daily (supervised/take away dose for DD/MM/YYYY)’
2. Ensure that the pharmacist on duty is made aware of any dose changes.
3. If no current prescription is available at the time of dispensing, but is expected that day, label the dose as
per the most recent dosage information available. Place a ‘Prescription Required’ sticker on the dose to
flag that a new prescription is due.
Controlled drug instalment prescriptions should only be prepared during off-peak times to
reduce the possibility of distractions.
Dispensing Process
A. Methadone
1. Select the correct brand of methadone from the CD safe, and dispense one formulation and one patient
at a time.
2. Measure the dose(s) using a glass measure(s)
3. Ask a pharmacist to accuracy check the volume. Use the prescription as a reference, accuracy check the
volume within the glass measure(s) and that the correct formulation has been dispensed
4. Pour the checked dose(s) into an appropriately sized bottle(s) and cap it. Doses should never be stored in
an open container e.g. a disposable cup.
5. If you have dispensed multiple instalments of the same volume, line up the filled bottles (containing
individually measured volumes) on a flat surface and check that the meniscus levels are the same.
B. Suboxone ™
1. Carefully select the appropriate strength of Suboxone™ from the CD safe and place the appropriate
number of tablets in a clear dispensing bag with a copy of the patient information leaflet.
2. Attach the label to the bottle/bag and initial the “disp by” box
3. If there is no current prescription present at the time of dispensing, attach a red sticker stating
‘Prescription Required’ to the dispensing label.
4. Pass to pharmacist for checking.

01/06/2023 © Boots 2023 SOP:
CD 6
DATE:
annually thereafter
Version 2


Checking and Supplying a Controlled Drug Instalment Prescription
Accuracy Check
1. Perform an accuracy check following SOP DISP5, ensuring the correct supervised and take-away
instalments and in the case of methadone the right brand have been prepared for the patient .
2. Bring any errors to the attention of the dispenser, have them rectified, enter details in the near miss log
3. Initial the “chk by” box on the label when you are satisfied the medication has been prepared correctly.
4. Store the pre-prepared doses of the controlled drug in the CD cabinet (unless handing out a dose(s)
immediately). Segregate medication for different patients and store each patient’s individually dispensed
containers in supply date order, ensuring that the container with the earliest supply date is placed to the
front.
The final accuracy and clinical checks can only be completed using a valid, current OST
prescription
Clinical Check and Supply (Hand out/Supervision)
1. Greet the patient and confirm his/her name. If the patient is not known to the pharmacist, confirm
his/her identity with another member of the team and ensure that the presenting patient is the patient
pictured on the patient treatment card.
Ask the patient to state information such as his/her name, address, medication expected,
quantity expected or other recorded information to confirm identity
2. Retrieve the relevant prescription. Check the prescription to ensure that an instalment of medication is
due and check the instalment record to ensure that it has not been issued already for this date.
3. Complete a clinical assessment of the prescription following SOP 4.
4. Check that the patient is in a fit condition to receive the supervised instalment. In the event the patient
appears to be intoxicated or behaves inappropriately, contact the prescriber to agree a course of action.
5. In the event of a missed dose:
• Methadone
• 1 day missed: Dispense the full dose and document the reason for the miss as per agreed
protocol with the prescriber
• 2 or more days missed: Explain to him/her that further supplies cannot be made; contact
the prescriber for confirmation on how to proceed
• Suboxone™
• 3 consecutive doses missed: Must be reassessed by the prescriber.
6. If any change to the prescribed dose has been necessary following the clinical check, document the
contact with the prescriber on the patient’s PMR, remember to request an amended prescription to
reflect the change.
7. Retrieve the prepared methadone instalment from the CD cabinet, Check that the label on the
container(s) corresponds with the prescription requirements for the day in question (i.e. the instalment
date and dose are correct) - take extra care if the prescriber has stipulated a dose change(s) part way
through the prescription.
Supervised doses must always be given exactly as per the doctor’s instructions. Take away
doses are only to be given directly to the patient, unless specifically instructed otherwise
by the prescriber

Checking and Supplying a Controlled Drug Instalment Prescription
Clinical Check and Supply (Hand out/Supervision) (continued)
1. Invite the patient to the designated supervision area (usually the patient consultation area). Ask the
patient to confirm the dose he/she is expecting. Give the dose to the patient:
• Offer to pour any liquid into a disposable cup after showing the patient the labelled container
and offer the patient a drink of water and chewing gum.
• Place tablet(s) on a 5ml spoon or in a measure, check that the patient does not have any chewing
gum or other substance in their mouth to which the tablet might adhere. Request the patient to
drink some water. Provide dose to the patient, advise the patient to place sublingual tablets
under his/her tongue, allow to dissolve and not to swallow them.
2. Observe the consumption of the dose. Have a short conversation with the patient and discreetly confirm
that the dose has been consumed
Supervision of Suboxone™ consumption can take five minutes or more for some patients
3. Supply any take-away doses and an appropriate measuring device if appropriate, and in the case of
Suboxone™ a patient information leaflet (leaflets can be printed from www.hpra.ie). In the event the
patient is a first-time recipient of Suboxone™, provide the patient with a warning card which the patient
should be instructed to carry with them at all times (patients should be advised of the importance of
notifying any healthcare professional providing medical treatment to them that they are receiving
Suboxone™ ). Offer to counsel the patient on the safe use of their medicine.
Counselling on the use of their medicine should included directions for use, common side
effects, action to be taken if a dose is missed, cautionary notices about the effects on the
ability to drive or operate machinery, interactions with other drugs, and the dangers of an
opioid intolerant person consuming Methadone/ Suboxone™
4. Remove and destroy the dispensing labels from empty containers before disposing of the empty
container appropriately

01/06/2023 © Boots 2023 SOP:
SUPERVISING PHARMACIST SIGNATURE:
CD 7
DATE: Audit due one month
annually thereafter
Version 2


How to Conduct the Patient Journey through the
Compression Hosiery Service
team members when providing the Compression Hosiery Service
Patient request for service
1. When a patient enquires or requests the service provide them with an overview and the Service
Patient Leaflet or refer to boots.ie/compression-hosiery-service, as relevant
2. If patient wants to proceed check if they have a private prescription
3. If they want to avail of the service:
• at a different time book inform them on how to book an appointment via boots.ie
• straight away or arrives for appointment request them to complete Section 1 of Service
Consultation Record Form (CRF)
4. Inform trained member of healthcare team and give them the CRF and if relevant, the private
prescription
• Measurements should be taken after legs have been rested and swelling is at a
minimum (ideally early morning)
• Inform patient of the chaperone policy
✓ • A prescription is not required to avail of the Service
• Patient with a Medical Card prescription can get eligible hosiery products through this
scheme and will not require a measuring & fitting consultation
Measuring and fitting consultation

1. Trained Advisor to collect compression hosiery file (with necessary items e.g. measuring tape, size
charts) and proceed to greet patient and bring them into the consultation room
2. Provide an overview of the consultation, advising that it will include taking a number of leg
measurements
3. Check patient’s information completing Section 1 of CRF. If the patient has a private prescription
relevant information on CRF
4. Obtain informed consent to proceed with the service
5. Determine the Standard, Class and length required referring to the patient’s indication, the Hosiery
Standards and Class Indication Tables Sheet, preference & scheme eligibility
6. Proceed to take necessary measurements, starting with the top leg measurement and then working
down and record accurately measurements from both legs on the CRF
Refer to the pharmacist if a caution or contraindication applies such as:

• Problem with arterial circulation
• Severe oedema (swelling) of the lower leg
• Local skin conditions e.g. dermatitis, recent skin graft
• Leg deformity
• Known sensitivity to material in the hosiery
• Has diabetes or rheumatoid arthritis
• Problems with nerves in the legs and feet leading to decreased sensation

01/06/2023
Review due : 01/06/2025
© Boots 2023
SOP:
COMP 1
Version 7
receipt of SOP then
annually thereafter
How to Conduct the Patient Journey through the
Compression Hosiery Service (contd.)
Measuring and fitting consultation continued

1. Refer to relevant manufacturer’s size chart to determine correct size and brand to supply, starting with
ankle measurement
2. Select the style and colour (where choice available) with the patient using relevant swatch samples &
note selection on CRF
3. Sign ‘measurements taken by’ section of the CRF
4. Explain to the patient how to apply & remove the hosiery and provide general care advice using the
laminated Compression Hosiery Fitting Advice and Care Instructions Sheet to support. Provide the
patient with this information sheet to read advising that you need to go to dispensary to check
availability of product
5. Go to dispensary with the CRF
• Where variance in measurements between legs, double check taken correctly

• Where unsure, refer to the pharmacist
• Class 2 or higher should only be provided following consultation and approval by the
✓ on-duty pharmacist
• If patient’s measurements do not fit the size range in one brand, check size range from
a different brand
• If measurements do not fit standard sizes, explain the “made to measure” option to the
patient
Dispensing the chosen product

1. Pharmacist to check the selected product is correct for patient referring to CRF, paying attention to
size and class and completes the relevant part in section 4 of the CRF
2. Dispenser to dispense chosen hosiery through computer through OTC scheme and calculate private
price, as applicable. Print item label & attach to space provided on CRF
3. Where item not in stock, ensure to order and check available from wholesaler.
4. Store the CRF in the ‘Order Waiting Delivery’ section of the compression hosiery folder and
dispense when arrives.
Closing the consultation
1. Trained Advisor to return to consultation room and inform the patient of the price and a realistic
delivery time if item not in stock. Close the consultation, checking if they have any questions. Give a
copy of the Service Patient Leaflet
2. Remind patient to read the fitting and care instructions provided with their hosiery, & if they
experience any pain or discomfort to remove the hosiery & contact pharmacy
3. Process the payment through the till and staple a copy of till receipt to the CRF. Where product not
in stock advise patient they will receive a text message when product ready to collect.
Pain or discomfort should not be experienced when wearing hosiery
Record keeping
4. File the CRF in the Secure Record Holder and store for 2 years

01/06/2023
Review due : 01/06/2025
© Boots 2023
SOP:
COMP 1
Version 7
receipt of SOP then
annually thereafter
Standard Operating Procedure (SOP) Training Log COMP 1 V7

Receive a Prescription
when receiving a prescription from a patient/representative who presents to the pharmacy, or when receiving
a prescription via Healthmail/the Boots Prescription Ordering App
Receiving a prescription where the patient/representative is present

1. Greet the patient/representative and receive their prescription(s).
2. Check the validity of the prescription.
3. Confirm and record the following information on the pharmacist information form (PIF) if any of the
information is missing or unclear:

• Patient name
• Patient address
• Patient telephone number
• Patient age (if under 12)
• Prior or known allergic reactions
• Eligibility under the community drugs schemes
• Items and quantities required
Refer to Operational Guidance for Community Drug Schemes
4. Check with a member of the dispensary team that the stock required for the prescription is available.
5. Confirm with the patient/representative when they would like to collect the prescription, and if they
would like to receive a text message when the prescription is ready. Make a note of the agreed collection
time on the PIF.
Refer to Operational Guidance for Community Drug Schemes
6. Place the prescription and the completed PIF in the designated area for queuing prescriptions.
Ensure that prescriptions for different patients, including patients who are
members of the same family, are kept separate from each other
Receiving a Prescription where patient/representative is not immediately present (e.g. prescription received
via Healthmail/Boots Prescription Ordering App
1. Receive the prescription via Healthmail/Boots Prescription Ordering App. .
2. Follow steps 2-4 as outlined above. Contact the patient should you require any further information/have
queries that require clarification/need to order stock to fulfil the prescription/etc.
Refer to Operational Guidance for use of Healthmail or Operational Guidance for
the provision of prescription services via the Boots App as appropriate
3. Contact patient to inform them their prescription is ready for collection
4. Place the printout of the Healthmail/Boots Prescription Ordering App prescription and the completed PIF
in the designated area for queuing prescriptions.
5. In the case of prescriptions received via the Boots Prescription Ordering App, annotate the PIF to indicate
that the prescription has been received via the app, and therefore the hard copy of the prescription will
be required when the patient presents to the store.
01/06/2023 SOP:
© Boots 2023
SUPERVISING PHARMACIST SIGNATURE: DATE: Audit due one month after DISP 1
SOP DISP 1 V3 Receive a Prescription

Label a Prescription
when entering prescription details onto a Patient Medical Record (PMR) to create the dispensing label used
during the prescription assembly process.
Pre-dispensing prescription review
1. Check that the details on the are prescription(s) are clear and legible. Refer to the patient/prescriber to
confirm any details which are unclear.
2. If there are multiple prescriptions, check that the prescriptions are for the same patient and separate any
that are for a different patient(s).
3. Perform any calculations required. Write all calculation workings on the back of the PIF to allow these to
be checked as part of the final accuracy check.
Dispensing the prescription using MPS
4. Using the prescription as a reference, enter the prescription details including the prescriber’s name and
date of the prescription on the PMR. For repeat prescriptions, ensure you have recorded the date and
location of last dispensing from the previous pharmacy where this is available. If the prescription has
repeats, please note in required field.
5. Ensure that the name, form, strength, quantity and directions for each item is entered accurately onto the
PMR. When ‘repeating’ items, give particular attention to strengths and directions which can change.
Refer to Operational Guidance on how to create a Patient Medication Record (PMR) and
the Operational Guidance for Prescription Record Keeping
6. If the prescription includes a drug which is listed on the interchangeable list as published by the HPRA,
ensure to select the preferred product unless the GP has indicated that the patient must be supplied with
a particular brand, or the patient has indicated a preference for a particular brand. For reference priced
products, make a record of the brand prescribed and the brand dispensed for transmission to the PCRS.
7. Any relevant information on drug interactions highlighted on MPS, must be brought to the attention of
the Pharmacist. All interaction warnings must be printed and available for review by the pharmacist.
It is the pharmacist’s responsibility to ensure that those involved in the dispensing
process are adequately trained and aware of the importance of alerting the pharmacist
to any interaction of note during labelling.
8. Accurately prepare and print all the labels ensuring the label includes clear instructions for use. ‘As
directed’ should not be used.
9. In the event an item of stock is temporarily unavailable, create a record for an owing.
Refer to Operational Guidance for Owings

10. For phased prescriptions, ensure the labels match the quantity to be supplied in each instalment
Refer to Operational Guidance for Phased Dispensing Arrangements
11. Annotate the following on the PIF associated with the prescription:
• Newly-prescribed medicines
• Changes to any dose, strength or form from the last entry on PMR
• Information on allergies from the PMR
• If this is an incidence of early dispensing
12. Check that the prescription details have been entered accurately.
13. Pass the medication labels, any interaction information, prescription and PIF on for assembly.

01/06/2023 © Boots 2023 SOP:
SUPERVISING PHARMACIST SIGNATURE: Audit due one month after DISP 2
SOP DISP 2 V4 Label a Prescription

Assemble a Prescription
This Standard Operating Procedure (SOP) must be followed by Pharmacists and Dispensary team
members when assembling medicines in accordance with a prescription in advance of clinical and
accuracy checks by the Pharmacist
1. Using the prescription, collect all the stock required in a nestable container.
2. Check that all tamper-proof seals are intact (unless stock is already marked as broken bulk) and that
the stock is in date.
3. Count or measure the required quantity of medicine into an appropriate child-proof container (unless
the patient has a specific valid reason to request otherwise). Leave any stock containers (marked as
broken bulk) or empty containers with the assembled items for checking.
4. Apply the dispensing label for each item to the appropriate container. Where possible, apply the label
to the original pack, ensuring the drug name, strength and 2-D barcode on the packaging remains
visible.
5. Provide a patient information leaflet (PIL) for each item and add a spoon, measuring cup or oral
syringe if necessary.
Additional PILs can be printed from www.hpra.ie or www.medicines.ie
6. Using the MPS Medicines Verification Software, scan the stock to verify the medicines are authentic.
Refer to Operational Guidance for the Falsified Medicines Directive using MPS
7. Once all the items on the prescription have been dispensed, check the accuracy of each assembled
item against the prescription, following steps 1-2 of ‘SOP DISP05 Complete an accuracy check of a
prescription.’ Record any errors identified at this stage on the near miss log and rectify them.
8. Endorse the prescription with the pharmacy stamp, the date of dispensing, the word ‘dispensed’ and
details of what has been dispensed.
9. Once all the items have been checked, initial the ‘disp’ part of each dispensing label to indicate to the
pharmacist that the initial accuracy check at time of assembly has been completed.
10. Using the prescription for reference, place each item into a nestable container.
11. Place the dispensed items together with the prescription and copy of the prescription, any
prescription receipts and the PIF in the designated area for prescriptions ready for pharmacist
clinical/accuracy check.
Place medicines requiring fridge or CD safe storage in the fridge/CD safe

unless an accuracy check can be completed immediately
SUPERINTENDENT PHARMACIST SIGNATURE:

DATE: Review due : 01/06/2025
01/06/2023 © Boots 2023 SOP:
SUPERVISING PHARMACIST SIGNATURE: DATE: Audit due one month DISP 3
Standard Operating Procedure (SOP) DISP3 V2 Training Log

Complete a Clinical Check of a Prescription
1. Check that the prescription is legally valid and that it meets the requirements of relevant community
drug schemes. Ensure that all details are clear and legible.
Refer to Operational Guidance for the Requirements of a Valid Prescription and

Operational Guidance for Community Drug Schemes
2. For repeat prescriptions, check if the prescription has been previously dispensed and confirm that the
intervals between dispensing are appropriate.
3. Use the reference sources provided through Medicines Complete to complete a clinical assessment of
the prescription.
Refer to Operational Guidance for using Medicines Complete
4. Ensure that the prescribed items are clinically appropriate for the patient at the time of dispensing in
the context of:
• Age, gender and weight of patient
• Medical history as indicated by the PMR
• Pregnancy and breastfeeding
• Any known allergies

• Dosage, form and route of administration prescribed
• Condition for which the medicine is being prescribed (if known)
• Duration of treatment
• Contraindications and special precautions (including drug and food interactions)
• Potential side effects
Take particular care with:
• Drugs with a narrow therapeutic index (e.g. warfarin, lithium, digoxin)
• Weekly dosage regimes (e.g. methotrexate)
• Drugs with a reducing dose (e.g. prednisolone)
• Instances of drugs being prescribed again with its usual initiation dose being
repeated (e.g. digoxin, amiodarone)
• New to market drugs or those prescribed infrequently
• High tech drugs
• Unlicensed medicines
• Patients with no or limited PMR
• High risk patients e.g. elderly patients, paediatric patients
• Hospital discharge prescriptions – watch out for unintentional
changes/omissions
5. Contact the prescriber to discuss any issues arising from the clinical assessment. Record details of this
discussion along with your name and date of intervention in the notes section of the PMR.
6. If a change to a prescription has been agreed with the prescriber, endorse the prescription with the
words “Prescriber contacted/PC” and record the details of the change. Request the prescriber to
issue a revised prescription.
7. Make notes of any relevant information (including any changes to the prescription) for discussion
with the patient at hand-out on the PIF.
01/06/2023 © Boots 2023 SOP:
SUPERVISING PHARMACIST SIGNATURE: DATE: Audit due one month DISP 4

Complete an Accuracy Check of a Prescription
1. For each item on the prescription, check:
a) Any calculations that have been carried out during the assembly process
b) The label against the prescription
• Patient name
• Drug name (including if the correct preferred product has been supplied in the case
of an interchangeable medicine)
• Dosage form and strength
• Quantity
• Dosage instructions
c) The stock container and dispensed product against the prescription
• Drug name
d) The label against the dispensed product
• Drug name
• Quantity
e) The label and prescription receipt against the prescription
• Patient name and address

• Prescriber name and address on prescription receipt
2. Check the expiry date of all items which have been dispensed and that each item has a PIL enclosed.
3. Bring any errors and/or omissions to the attention of the dispenser and have them rectified. Record
any such errors on the near miss log.
4. Once satisfied that each item is correct, initial the ‘check’ box on the dispensing label to confirm that
the second check has been completed (clinical and accuracy checks by pharmacist).
5. Ensure that each prescription (and GMS copy where appropriate) has been endorsed with the
pharmacy stamp, the date of dispensing, the word ‘dispensed’ and the details of the items which
have been dispensed.
6. Using the prescription as a reference, count the items into a dispensing bag. Add any prescription
receipt, seal the bag and securely attach the bag label with the patient’s name and address.
7. In the event of an owing, ensure a copy of the prescription has been placed in an owings box to allow
the owing to be made up from a prescription when stock is received.
8. If the patient/representative is waiting, hand out the dispensed items following ‘SOP DISP 6 Hand out
a Prescription’ and make any necessary entries in the CD register.
9. If the patient/representative is calling back, send any agreed text message. Place the prescription(s),
PIF, and any prescription receipts required to be signed under the community drugs schemes in a
wallet and place in the retrieval system.
Refer to Operational Guidance for the Prescription Retrieval System and

Operational Guidance for Text Messaging
10. Store the checked medication in the designated storage area, taking care that any fridge lines are
stored in the pharmacy fridge and CD lines are stored in the CD safe.

01/06/2023 © Boots 2023 SOP:
DISP 5

Hand Out a Prescription
1. Greet the customer and ask for the name and address of the patient whose medication is to be
collected.
2. Locate the wallet with the patient’s prescription in the retrieval system. Ask patient to say their name
and address and check it matches the label on the wallet and check this corresponds to the relevant
bag(s) from the prescription storage area. Remember to collect any additional item(s) which may be
stored in the pharmacy fridge or CD safe. Scan the bag label to supply the medicines to a patient.
Refer to Operational Guidance for the Falsified Medicines Directive using MPS
3. Offer the patient/representative the opportunity to be provided with counselling on the safe use of
their medicine(s). Ensure that any specific counselling points included on the PIF are discussed with
the patient. It may be necessary to consider the use of the patient consultation room to safeguard a
patient’s privacy during patient counselling.
Patient counselling may include:

• The name, strength and form of the prescribed medicine, the reason for and
duration of its use
• Directions for use including any precautions necessary e.g. use with food etc
• Expected effect of the medicine and potential side effects
• The importance of compliance with the prescribed directions for use and techniques
for self-monitoring.
• Actions to take in the event of a missed dose
• Correct storage of the medicine and disposal of any unused medicines
• Reference to patient information leaflet
• Information about any generic substitution if relevant
4. Ask the patient / representative if he/she has any queries about the medicine.
5. For repeat prescriptions, offer the customer the opportunity to avail of the repeat prescription
service.
Refer to Operational Guidance for the Repeat Prescription Service
6. Request the patient/representative to sign any prescription receipt(s) required under the community
drugs schemes. If necessary, advise the patient/representative about any items which are owed and
the expected date when these will be available for collection. Charge the patient any fee indicated on
the prescription bag label.
7. File any completed prescriptions or copies of prescriptions and signed prescription receipts with the
prescriptions awaiting verification. Place any PS prescriptions in the relevant section of the PS file.
Discard the completed PIF in confidential waste.

01/06/2023 © Boots 2023 SOP:
DISP 6

Emergency Contraception Service – New Online Booking Process
Operational Changes Overview
Introduction
From Thursday, 23rd November 2023 Boots customers will have the opportunity to book an
appointment online for the Emergency Contraception (EC) Service. An overview of the key changes are included
below. Walk-in appointments will also remain. A new version of Operational Guide 20: Provision of
Contraception Services, which incorporates all these changes is also now available.
Key Points
1. Customer online booking will use Boots Appointment Management System, which is hosted by Swiftqueue
2. EC appointments made via Swiftqueue platform must be processed ideally at the time of appointment
attendance or at the latest before the end of each day e.g. marked as Complete, DNA or Did Not Attend, etc.)
for both reporting and GDPR purposes. Cannot complete is used where the customer attends their
consultation but is not eligible for the service at the time. The reason for this can be added to the digital form,
using the Edit Response function – see video below
3. McLernon Pharmacy System (MPS) record keeping - Where a patient is availing of the private EC Service and
has completed the Swiftqueue digital form, there is no longer a need to record on MPS. Recording for other
scheme eligibility on MPS remains
4. Pharmacist consultation - Whilst using the online platform enables the pharmacist to have the medication
ready to supply when the patient arrives, they must always receive a pharmacist consultation to ensure safe
and effective use of the medicine supplied. SOP EC1, and EC2 have been updated accordingly.
5. Pharmacist digital form editing – Note: The Swiftqueue digital pre-consultation form defaults to checking
eligibility for provision of EllaOne or ulipristal so in cases where levonorgestrel is considered the medicine of
choice based on customer responses, the ‘edit response’ function must be used, and associated questions or
sections completed. This can be done using the pharmacy iPad if convenient. See overview of this process via
short video example below
6. Accessing the Swiftqueue system - Where a locum pharmacist wants to be provided with login details for the
Swiftqueue system this can be requested for them by a member of Boots management team in store. Allow up
to 3 working days for access to be provided. Access to the system can be provided to one or more Boots
stores, and this needs to be specified at the time of a request.
Key Resources
• Video demonstrating overview of journey through Swiftqueue
Pharmacist review of and Edit Response of customer completed record form – approx. 3 minutes
• Quick Reference Guide
Pharmacy Office Ireland – November 2023

How to Manage an Enquiry or Request for the Emergency Contraception
(EC) Service
This Standard Operating Procedure (SOP) must be followed by Pharmacists and

Healthcare team members when they get a request for the Emergency Contraception
(EC) Service
Responsible: Healthcare Team
1. When a patient requests or enquires about getting emergency contraception (EC):

a. in the pharmacy, check if they have made an online appointment and inform
the on-duty pharmacist
b. by phone advise them that they can book a same day appointment online by
visiting boots.ie/emergency-contraception-service or come to the pharmacy for
Member
a walk-in appointment
• Only women aged 17 years and over are eligible for this service
• Inform the patient of the cost of the service as appropriate or that can
get free if in HSE eligible age group and provide their PPSN or have a
Medical Card
• If applicable, explain the chaperone policy
• Emergency Contraception is more effective the sooner it is taken
2. For any other service questions always refer the patient to the on-duty pharmacist
• Always handle requests with discretion and sensitivity

• If the pharmacist is busy give the patient an appropriate waiting time
• Emergency Contraception cannot be supplied to a third party

• Advance supply of Emergency Contraception is not permitted
• If a patient had unprotected sex more than 120 hours earlier they are
not eligible for this service the pharmacist should refer to an alternative
service provider

21/11/2023
Review due : 21/11/2025
© Boots 2023
SOP:
EC1
Version 11
receipt of SOP then
annually thereafter

Service
This Standard Operating Procedure (SOP) must be followed by Pharmacists when providing an
Emergency Contraception (EC) Service consultation for women aged 17 years and over
1. a. Where online pre-consultation record form completed review patient responses and collect
emergency contraception medication based on eligibility. Greet the patient and bring them
into the consultation room. Inform them of chaperone policy and fee as relevant
b. Where walk-in request greet the patient and bring them into the consultation room. Inform
them of chaperone policy and fee as relevant. Complete Boots EC Consultation Record
Form (CRF) with the patient and obtain informed consent to proceed with the service
• Be conscious of potential of non-consensual intercourse (e.g. rape/sexual assault),

child protection and vulnerable adult issues - refer to appropriate body, as relevant
• Provide details of the National 24-Hour Sexual Violence Helpline 1800 77 8888 for
additional support, where relevant
• Ensure information and contact details (including opening hours) for other EC service
providers and the nearest Rape Crisis Centre is available for reference in consultation
room & up to date
2. Where not eligible for ulipristal 30mg or requests levonorgestrel 1500mcg note necessary
detail on record form and complete levonorgestrel specific questions. In digital form this is
done using ‘Edit Response’ functionality and following prompts based on responses
• Customer questions completed at time of online booking relate to ulipristal
eligibility only. Use ‘Edit Response’ feature to complete levonorgestrel eligibility
questions or to record specific information
• Pharmacists must process online digital form using their specific username or
enter their name on digital form using the Edit Response feature
3. Confirm patient’s eligibility based on responses and check if they have any questions
• If not eligible complete the relevant section of paper or online record form noting reason and
advice given, referring to alternative service provider as appropriate & close consultation.
• If eligible provide patient with Boots EC Patient Advice leaflet. Guide them through the
leaflet, covering the points included in the leaflet, these are also covered in the video
located on boots.ie/emergency-contraception-service page.
• Always consult product SmPC and other up-to-date reference sources as
necessary to determine appropriateness of supply e.g. risk from contraceptive
failure, drug interactions, use in breast-feeding, adverse reactions,
contraindications
• Provide EC in line with any guidance provided by the Pharmaceutical Society of
Ireland (PSI) and also the PSI’s Code of Conduct for Pharmacists e.g. cannot be
provided to a third party or as advanced supply
4. Remind the patient that it’s more effective the sooner it’s taken. Provide the patient with a
copy of the relevant EC product Patient Information Leaflet (PIL), as included with the
medicine packaging
22/11/2023
Review due : 22/11/2025
© Boots 2023
SOP:
EC2
Version 14
receipt of SOP then
annually thereafter
Service (cont.)
6. Collect necessary medication, if not already done and provide to the patient
7. Process the payment for the service, if relevant at the healthcare till
8. Record HSE reimbursable supply on the dispensary computer system and HSE portal (as
applicable), using the recommended scheme based on claim eligibility e.g. Medical Card
through GMS Scheme
• For details on record keeping and claim processing refer to Operational Guidance
for the provision of Contraception Services
9. a. Process online appointment in Appointments Management System e.g. ‘complete’ where

eligible or ‘Cannot Complete’ if ineligible. Pharmacist who completed consultation should
use their username for this process or enter pharmacist name on form using Edit
Response feature
b. File paper CRFs in the Secure Record Holder (in chronological order). Remove EC
Record Forms on a monthly basis, store with other prescriptions and keep for 2 years
• If supply to a patient is likely to be affected by a pharmacist’s personal or moral

standards the Superintendent Pharmacist and Supervising Pharmacist must be
informed

22/11/2023
Review due : 22/11/2025
© Boots 2023
SOP:
EC2
Version 14
receipt of SOP then
annually thereafter

Sop: Disp 7: Standard Operating Procedure (Boots Retail Ireland LTD)

Uploaded by

Copyright:

Available Formats

Sop: Disp 7: Standard Operating Procedure (Boots Retail Ireland LTD)

Uploaded by

Document Information

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Sop: Disp 7: Standard Operating Procedure (Boots Retail Ireland LTD)

Uploaded by

Copyright:

Available Formats

Responding to a request for an emergency supply of a

YES Emergency supply not possible

Is the prescriber unable to Is there an immediate need for the

Has the prescriber NO NO

SUPERINTENDENT PHARMACIST SIGNATURE: DATE: Review due : 01/06/2025

Standard Operating Procedure (Boots Retail Ireland Ltd)

Standard Operating Procedure (Boots Retail Ireland Ltd)

All pharmacy incidents (including dispensing errors) cont.

Investigation of Incident and Completion of PIERs Report

SUPERINTENDENT PHARMACIST SIGNATURE: DATE: Review due : 01/06/2025

Standard Operating Procedure (Boots Retail Ireland Ltd)

Standard Operating Procedure (Boots Retail Ireland Ltd)

Refer to Medisure Operational Guidance on BootsLive

1. Follow the relevant steps outlined in SOP DISP 1 Receive a Prescription.

Labelling a prescription to be supplied as a Boots Medisure Pack

Assembling medicines to be supplied as a Boots Medisure Pack

1. Follow the relevant steps outlined in SOP DISP 3 Assemble a Prescription.

6. Check that each blister contains the correct medicines.

Completing a clinical and accuracy check of a Medisure Pack [Pharmacist]

SUPERINTENDENT PHARMACIST SIGNATURE: DATE: Review due : 01/06/2025

Standard Operating Procedure (Boots Retail Ireland Ltd)

Standard Operating Procedure (Boots Retail Ireland Ltd)

licensed by the HPRA

Standard Operating Procedure (Boots Retail Ireland Ltd)

Standard Operating Procedure (Boots Retail Ireland Ltd)

1. Receive a prescription for an unlicensed/exempt medicinal product

DATE: Review due : 01/06/2025

Standard Operating Procedure (Boots Retail Ireland Ltd)

Standard Operating Procedure (Boots Retail Ireland Ltd)

Prescription Service (NVPS) which is currently unavailable in Boots Pharmacies.

Refer to Operational Guidance for the Requirements of a Valid Prescription

Standard Operating Procedure (Boots Retail Ireland Ltd)

Standard Operating Procedure (Boots Retail Ireland Ltd)

Electronic Transfer of Prescriptions

Refer to Operational Guidance on the use of Healthmail during COVID-19

Validity Period of Prescriptions

Standard Operating Procedure (Boots Retail Ireland Ltd)

considers it appropriate and necessary.

Standard Operating Procedure (Boots Retail Ireland Ltd)

A. Emergency Supply at the request of the Patient

prescription only medicinal product at the request of a patient.

2. A pharmacist is permitted to supply a Schedule 2, 3 or 4 Controlled Drug at the request of a patient

B. Emergency Supply at the request of the Prescriber

SUPERINTENDENT PHARMACIST SIGNATURE: DATE: Review due : 01/06/2025

Standard Operating Procedure (Boots Retail Ireland Ltd)

Standard Operating Procedure (Boots Retail Ireland Ltd)

This Standard Operating Procedure (SOP) must be followed by Pharmacists and

• Always handle requests with discretion and sensitivity

• If the pharmacist is busy give the patient an appropriate waiting time

• Emergency Contraception cannot be supplied to a third party

SUPERINTENDENT PHARMACIST SIGNATURE: DATE:

Standard Operating Procedure (Boots Retail Ireland Ltd)

• Be conscious of potential of non-consensual intercourse (e.g. rape/sexual assault),

2. Complete Boots EC Consultation Record Form (CRF).

SUPERINTENDENT PHARMACIST SIGNATURE: DATE:

• If supply to a patient is likely to be affected by a pharmacist’s personal or moral

SUPERINTENDENT PHARMACIST SIGNATURE: DATE:

Standard Operating Procedure (Boots Retail Ireland Ltd)

and if a query arises contact the prescriber for resolution.